{"collection_queue":{},"coverage":{"basis":"declared","collection_issues":[],"coverage_start":"2023-01-01","explained_count":2,"material_issue_count":0,"minor_discrepancy_count":0,"newer_pending_count":0,"note":"All indexed substantive director notices and relevant meeting, grant, exercise, lapse, placement and annual-report context through 30 October 2026 were reviewed against the existing director rows. Director grants, exercises and lapses remain tied to named Appendix 3Y records; aggregate issuer issues are not assigned to a director without support.","notice_count":13,"pending_notice_count":0,"required_context_count":0,"reviewed_at":"2026-11-02T13:55:35Z","reviewed_notice_count":13,"reviewed_through":"2026-10-30","status":"complete","unclassified_note_count":0},"entities":{"andrew_bantock":{"entity_id":"andrew_bantock","investor_id":null,"kind":"person","management_id":null,"name":"Andrew Bantock","notes":[],"relationships":[],"roles":[{"end_date":null,"role":"Director","source_ids":["2924-02745977-6A1183092","2924-02752572-6A1185915","2924-02679622-6A1155542"],"start_date":null}]},"carmu_super_fund":{"entity_id":"carmu_super_fund","investor_id":null,"kind":"trust","management_id":null,"name":"Murray Philip Hill & Carol Ann Hill <Carmu Super Fund A/C>","notes":[],"relationships":[],"roles":[]},"carol_hill":{"entity_id":"carol_hill","investor_id":null,"kind":"person","management_id":null,"name":"Carol Ann Hill","notes":[],"relationships":[{"end_date":null,"entity_id":"murray_hill","relationship":"Spouse of director Murray Hill.","source_ids":["2924-03048341-6A1308123","2924-02745976-6A1183091"],"start_date":null},{"end_date":null,"entity_id":"carmu_super_fund","relationship":"Trustee and beneficiary with Murray Philip Hill.","source_ids":["2924-03048341-6A1308123","2924-02745976-6A1183091"],"start_date":null}],"roles":[]},"cumulus_mda_clients":{"entity_id":"cumulus_mda_clients","investor_id":null,"kind":"reporting_group","management_id":null,"name":"Clients of MDAs operated by FinClear Execution Limited and managed by Cumulus Wealth Pty Ltd","notes":["Annexure reports separate client-level trades; aggregate group holdings are not used to infer client positions."],"relationships":[{"end_date":null,"entity_id":"cumulus_wealth","relationship":"MDA manager and reporting substantial holder in Form 605.","source_ids":["2924-02768945-6A1192526"],"start_date":null},{"end_date":null,"entity_id":"finclear","relationship":"Execution operator for MDA clients whose trades are listed in Annexure 1.","source_ids":["2924-02768945-6A1192526"],"start_date":null}],"roles":[]},"cumulus_wealth":{"entity_id":"cumulus_wealth","investor_id":null,"kind":"company","management_id":null,"name":"Cumulus Wealth Pty Ltd","notes":[],"relationships":[],"roles":[]},"david_paradice":{"entity_id":"david_paradice","investor_id":null,"kind":"person","management_id":null,"name":"David Paradice","notes":[],"relationships":[{"entity_id":"paradice_investment_management","relationship":"Notice states relevant interests are the same as the body corporate under section 608(3)(a), with voting power over 20%.","source_ids":["2924-02898912-6A1245388"]}],"roles":[]},"define_super_fund":{"entity_id":"define_super_fund","investor_id":null,"kind":"trust","management_id":null,"name":"Define Consulting Pty Ltd ATF the Define Superannuation Fund","notes":[],"relationships":[],"roles":[]},"finclear":{"entity_id":"finclear","investor_id":null,"kind":"company","management_id":null,"name":"FinClear Execution Limited","notes":[],"relationships":[],"roles":[]},"hsbc_nominees_australia":{"entity_id":"hsbc_nominees_australia","investor_id":null,"kind":"company","management_id":null,"name":"HSBC Nominees (Australia) Ltd","notes":[],"relationships":[],"roles":[]},"murray_carol_carmu_group":{"entity_id":"murray_carol_carmu_group","investor_id":null,"kind":"reporting_group","management_id":null,"name":"Murray Philip Hill and Carol Ann Hill jointly as trustees and beneficiaries of the Carmu Super Fund account","notes":[],"relationships":[{"end_date":null,"entity_id":"murray_hill","relationship":"Trustee and beneficiary of the joint account.","source_ids":["2924-03048341-6A1308123"],"start_date":null},{"end_date":null,"entity_id":"carol_hill","relationship":"Trustee and beneficiary of the joint account.","source_ids":["2924-03048341-6A1308123"],"start_date":null}],"roles":[]},"murray_hill":{"entity_id":"murray_hill","investor_id":null,"kind":"person","management_id":null,"name":"Murray Philip Hill","notes":[],"relationships":[{"end_date":null,"entity_id":"carol_hill","relationship":"Spouse; relevant interests disclosed as direct and indirect.","source_ids":["2924-03048341-6A1308123","2924-02745976-6A1183091"],"start_date":null},{"end_date":null,"entity_id":"carmu_super_fund","relationship":"Trustee and beneficiary with Carol Ann Hill.","source_ids":["2924-03048341-6A1308123","2924-02745976-6A1183091"],"start_date":null}],"roles":[{"end_date":null,"role":"Director","source_ids":["2924-03048341-6A1308123","2924-02745976-6A1183091"],"start_date":null}]},"paradice_investment_management":{"entity_id":"paradice_investment_management","investor_id":null,"kind":"company","management_id":null,"name":"Paradice Investment Management Pty Ltd","notes":[],"relationships":[],"roles":[]},"scott_perry":{"entity_id":"scott_perry","investor_id":null,"kind":"person","management_id":null,"name":"Scott Perry","notes":[],"relationships":[],"roles":[{"end_date":null,"role":"Director","source_ids":["2924-02929414-6A1257493","2924-02979360-6A1278607","2924-03032143-6A1301053"],"start_date":null}]},"shane_mcbride":{"entity_id":"shane_mcbride","investor_id":null,"kind":"person","management_id":null,"name":"Shane McBride","notes":[],"relationships":[{"end_date":null,"entity_id":"sjjzt_family_trust","relationship":"KMP associated with registered holder listed for the performance-right conversion.","source_ids":["2924-03134671-6A1343448"],"start_date":null}],"roles":[]},"sjjzt_family_trust":{"entity_id":"sjjzt_family_trust","investor_id":null,"kind":"trust","management_id":null,"name":"SJJZT Pty Ltd ATF SJJZT Family Trust","notes":[],"relationships":[],"roles":[]},"sprott_group":{"entity_id":"sprott_group","investor_id":null,"kind":"reporting_group","management_id":null,"name":"Sprott Inc. and Sprott Group Entities","notes":["The aggregate group relevant interest is not a separate portfolio; events below preserve each disclosed SAM USA trade row."],"relationships":[{"end_date":null,"entity_id":"sprott_sam_usa","relationship":"Sprott Inc. and controlled Sprott Group Entities have the same relevant interests as SAM USA through control under Corporations Act s608(3).","source_ids":["2924-02867751-6A1231616"],"start_date":null}],"roles":[]},"sprott_sam_usa":{"entity_id":"sprott_sam_usa","investor_id":null,"kind":"company","management_id":null,"name":"Sprott Asset Management USA Inc. (SAM USA)","notes":["Fund and investment manager identified as the trade holder in Form 604 Annexure A."],"relationships":[],"roles":[]},"stephen_mann":{"entity_id":"stephen_mann","investor_id":null,"kind":"person","management_id":null,"name":"Stephen Thomas Mann","notes":[],"relationships":[],"roles":[{"end_date":null,"role":"Director","source_ids":["2924-02752572-6A1185915","2924-03032143-6A1301053","2924-03038701-6A1303990"],"start_date":null}]},"tracy_mann":{"entity_id":"tracy_mann","investor_id":null,"kind":"person","management_id":null,"name":"Tracy Sophia Mann","notes":[],"relationships":[],"roles":[{"end_date":null,"role":"Director","source_ids":["2924-02752572-6A1185915","2924-03038701-6A1303990"],"start_date":null}]}},"errors":[],"events":[{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Performance rights expired unvested; no cash consideration.","contract_details":"","currency":"AUD","date":"2026-09-11","date_end":null,"economic_event_id":"2924-03134678-6A1343454:carol_hill:expiry:2025_sti_performance_rights:2:20","entity_id":"carol_hill","event_id":"2924-03134678-6A1343454:carol_hill:expiry:2025_sti_performance_rights:2:20","event_type":"expiry","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"257,363 2025 STI Performance Rights expired unvested.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":257363,"quantity_acquired":0,"quantity_disposed":257363,"reconciliation_note":"","security_class":"2025 STI Performance Rights","source_refs":[{"locator":"Part 1, number disposed","page":2,"source_id":"2924-03134678-6A1343454"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"390,091 2025 STI Performance Rights converted on vesting/exercise into ordinary shares. $0.25 is an estimated closing-price valuation, not cash consideration.","contract_details":"","currency":"AUD","date":"2026-09-11","date_end":null,"economic_event_id":"2924-03134678-6A1343454:carol_hill:exercise:ordinary_fully_paid_shares:2:19","entity_id":"carol_hill","event_id":"2924-03134678-6A1343454:carol_hill:exercise:ordinary_fully_paid_shares:2:19","event_type":"exercise","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"390,091 ordinary shares acquired; 390,091 2025 STI Performance Rights converted on vesting and exercise to Ordinary FP Shares.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":390091,"quantity_acquired":390091,"quantity_disposed":0,"reconciliation_note":"","security_class":"Ordinary fully paid shares","source_refs":[{"locator":"Part 1, number acquired/disposed and nature of change","page":2,"source_id":"2924-03134678-6A1343454"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Off-market transfer between direct and indirect associates; disclosed $0.245/share is stated value, not cash consideration.","contract_details":"","currency":null,"date":"2026-01-21","date_end":null,"economic_event_id":"2924-03048341-6A1308123:murray_hill:transfer_out:0","entity_id":"murray_hill","event_id":"2924-03048341-6A1308123:murray_hill:transfer_out:0","event_type":"transfer_out","exercise_price":null,"expiry_date":null,"holding_after":540909,"holding_before":994756,"interest_type":"direct","notes":"","original_wording":"Transfer of 453,847 ordinary shares from Murray Philip Hill.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":453847,"quantity_acquired":0,"quantity_disposed":453847,"reconciliation_note":"","security_class":"Ordinary fully paid shares","source_refs":[{"locator":"Part 1, before/after positions and nature of change","page":2,"source_id":"2924-03048341-6A1308123"}],"supersedes":[],"venue":"off_market","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Off-market transfer between direct and indirect associates; disclosed $0.245/share is stated value, not cash consideration.","contract_details":"","currency":null,"date":"2026-01-21","date_end":null,"economic_event_id":"2924-03048341-6A1308123:carol_hill:transfer_out:1","entity_id":"carol_hill","event_id":"2924-03048341-6A1308123:carol_hill:transfer_out:1","event_type":"transfer_out","exercise_price":null,"expiry_date":null,"holding_after":6730234,"holding_before":7625873,"interest_type":"indirect","notes":"","original_wording":"Transfer of 895,639 ordinary shares from Carol Ann Hill.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":895639,"quantity_acquired":0,"quantity_disposed":895639,"reconciliation_note":"","security_class":"Ordinary fully paid shares","source_refs":[{"locator":"Part 1, before/after positions and nature of change","page":2,"source_id":"2924-03048341-6A1308123"}],"supersedes":[],"venue":"off_market","view":"directors"},{"account_entity_id":"carmu_super_fund","cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Off-market transfer between direct and indirect associates; disclosed $0.245/share is stated value, not cash consideration.","contract_details":"","currency":null,"date":"2026-01-21","date_end":null,"economic_event_id":"2924-03048341-6A1308123:carmu_super_fund:transfer_in:2","entity_id":"murray_carol_carmu_group","event_id":"2924-03048341-6A1308123:carmu_super_fund:transfer_in:2","event_type":"transfer_in","exercise_price":null,"expiry_date":null,"holding_after":2731304,"holding_before":1381818,"interest_type":"indirect","notes":"","original_wording":"Transfer into the Carmu Super Fund account of 1,349,486 ordinary shares.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":1349486,"quantity_acquired":1349486,"quantity_disposed":0,"reconciliation_note":"","security_class":"Ordinary fully paid shares","source_refs":[{"locator":"Part 1, before/after positions and nature of change","page":2,"source_id":"2924-03048341-6A1308123"}],"supersedes":[],"venue":"off_market","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"","contract_details":"","currency":"AUD","date":"2025-12-16","date_end":null,"economic_event_id":"2924-03038701-6A1303990:tracy_mann:expiry:unlisted_options_exercisable_at_$0.61:6:22","entity_id":"tracy_mann","event_id":"2924-03038701-6A1303990:tracy_mann:expiry:unlisted_options_exercisable_at_$0.61:6:22","event_type":"expiry","exercise_price":0.61,"expiry_date":"2025-12-16","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"600,000 options held by Tracy Sophia Mann disposed; options exercisable at $0.61 on or before 16 December 2025; notice records nil consideration.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":600000,"quantity_acquired":0,"quantity_disposed":600000,"reconciliation_note":"","security_class":"Unlisted options exercisable at $0.61","source_refs":[{"locator":"Stephen Mann Appendix 3Y, number disposed","page":6,"source_id":"2924-03038701-6A1303990"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"","contract_details":"","currency":"AUD","date":"2025-12-16","date_end":null,"economic_event_id":"2924-03038701-6A1303990:carmu_super_fund:expiry:unlisted_options_exercisable_at_$0.61:2:21","entity_id":"carmu_super_fund","event_id":"2924-03038701-6A1303990:carmu_super_fund:expiry:unlisted_options_exercisable_at_$0.61:2:21","event_type":"expiry","exercise_price":0.61,"expiry_date":"2025-12-16","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"1,900,000 unlisted options in Carmu Super Fund account expired unexercised on 16 December 2025.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":1900000,"quantity_acquired":0,"quantity_disposed":1900000,"reconciliation_note":"","security_class":"Unlisted options exercisable at $0.61","source_refs":[{"locator":"Murray Hill Appendix 3Y, number disposed","page":2,"source_id":"2924-03038701-6A1303990"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Estimated valuation $0.1364 per Service Option is not cash consideration.","contract_details":"","currency":"AUD","date":"2025-12-02","date_end":null,"economic_event_id":"2924-03032143-6A1301053:tracy_mann:grant:service_options:5","entity_id":"tracy_mann","event_id":"2924-03032143-6A1301053:tracy_mann:grant:service_options:5","event_type":"grant","exercise_price":0.41,"expiry_date":"2029-12-01","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"432,570 Service Options acquired by Tracy Sophia Mann; exercisable at $0.41 and expiring 1 December 2029.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":432570,"quantity_acquired":432570,"quantity_disposed":0,"reconciliation_note":"","security_class":"Service Options","source_refs":[{"locator":"Stephen Mann Appendix 3Y, number acquired","page":9,"source_id":"2924-03032143-6A1301053"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Estimated valuation $0.43 per Service Right is not cash consideration.","contract_details":"","currency":"AUD","date":"2025-12-02","date_end":null,"economic_event_id":"2924-03032143-6A1301053:stephen_mann:grant:service_rights:8:25","entity_id":"stephen_mann","event_id":"2924-03032143-6A1301053:stephen_mann:grant:service_rights:8:25","event_type":"grant","exercise_price":null,"expiry_date":"2028-11-30","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"130,000 Service Rights granted; expiring 30 November 2028.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":130000,"quantity_acquired":130000,"quantity_disposed":0,"reconciliation_note":"","security_class":"Service Rights","source_refs":[{"locator":"Stephen Thomas Mann Appendix 3Y, number acquired","page":8,"source_id":"2924-03032143-6A1301053"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Granted following shareholder approval 27 November 2025; disclosed estimated valuation $0.1364 per option is not cash consideration.","contract_details":"","currency":"AUD","date":"2025-12-02","date_end":null,"economic_event_id":"2924-03032143-6A1301053:scott_perry:grant:service_options:2:23","entity_id":"scott_perry","event_id":"2924-03032143-6A1301053:scott_perry:grant:service_options:2:23","event_type":"grant","exercise_price":0.41,"expiry_date":"2029-12-01","holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"Issue of 695,837 Service Options exercisable at $0.41, expiring 1 December 2029.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":695837,"quantity_acquired":695837,"quantity_disposed":0,"reconciliation_note":"","security_class":"Service Options","source_refs":[{"locator":"Scott Perry Appendix 3Y, number acquired and holdings after","page":2,"source_id":"2924-03032143-6A1301053"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Estimated valuation $0.305 per right is not cash consideration.","contract_details":"","currency":"AUD","date":"2025-12-02","date_end":null,"economic_event_id":"2924-03032143-6A1301053:carol_hill:grant:2025_sti_performance_rights:4","entity_id":"carol_hill","event_id":"2924-03032143-6A1301053:carol_hill:grant:2025_sti_performance_rights:4","event_type":"grant","exercise_price":null,"expiry_date":"2027-12-01","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"647,454 2025 STI Performance Rights granted to Carol Ann Hill, expiring 1 December 2027.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":647454,"quantity_acquired":647454,"quantity_disposed":0,"reconciliation_note":"","security_class":"2025 STI Performance Rights","source_refs":[{"locator":"Murray Hill Appendix 3Y, number acquired","page":5,"source_id":"2924-03032143-6A1301053"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Estimated valuation $0.24 per right is not cash consideration.","contract_details":"","currency":"AUD","date":"2025-12-02","date_end":null,"economic_event_id":"2924-03032143-6A1301053:carol_hill:grant:2025_lti_performance_rights:3","entity_id":"carol_hill","event_id":"2924-03032143-6A1301053:carol_hill:grant:2025_lti_performance_rights:3","event_type":"grant","exercise_price":null,"expiry_date":"2029-12-01","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"658,245 2025 LTI Performance Rights granted to Carol Ann Hill, expiring 1 December 2029.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":658245,"quantity_acquired":658245,"quantity_disposed":0,"reconciliation_note":"","security_class":"2025 LTI Performance Rights","source_refs":[{"locator":"Murray Hill Appendix 3Y, number acquired","page":5,"source_id":"2924-03032143-6A1301053"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Estimated valuation $0.1364 per option is not cash consideration.","contract_details":"","currency":"AUD","date":"2025-12-02","date_end":null,"economic_event_id":"2924-03032143-6A1301053:carmu_super_fund:grant:service_options:2","entity_id":"carmu_super_fund","event_id":"2924-03032143-6A1301053:carmu_super_fund:grant:service_options:2","event_type":"grant","exercise_price":0.41,"expiry_date":"2029-12-01","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"1,737,304 Service Options granted to Murray Hill and Carol Hill jointly as trustees/beneficiaries of the Carmu Super Fund; exercisable at $0.41 and expiring 1 December 2029.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":1737304,"quantity_acquired":1737304,"quantity_disposed":0,"reconciliation_note":"","security_class":"Service Options","source_refs":[{"locator":"Murray Hill Appendix 3Y, number acquired","page":5,"source_id":"2924-03032143-6A1301053"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"not_disclosed","consideration_details":"On-market purchase; notice gives $0.2537 per share but does not explicitly state total cash consideration.","contract_details":"","currency":"AUD","date":"2025-08-14","date_end":null,"economic_event_id":"2924-02979360-6A1278607:scott_perry:purchase:fully_paid_ordinary_shares:2:26","entity_id":"scott_perry","event_id":"2924-02979360-6A1278607:scott_perry:purchase:fully_paid_ordinary_shares:2:26","event_type":"purchase","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"990,280 fully paid ordinary shares acquired on market at $0.2537 per share.","percentage":null,"percentage_basis":null,"price":0.2537,"price_basis":"disclosed","quantity":990280,"quantity_acquired":990280,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Part 1, number acquired/value and nature of change","page":2,"source_id":"2924-02979360-6A1278607"}],"supersedes":[],"venue":"on_market","view":"directors"},{"account_entity_id":"define_super_fund","cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Service rights lapsed because conditions were not met; no cash consideration.","contract_details":"The Appendix 3H reports an issuer-wide class lapse; the 2023 grant and 2025 annual-report position identify Andrew Bantock's Define Super Fund account.","currency":"AUD","date":"2025-05-16","date_end":null,"economic_event_id":"2924-02947537-6A1264894:andrew_bantock:define_super_fund:cancellation:service_rights:0","entity_id":"andrew_bantock","event_id":"2924-02947537-6A1264894:andrew_bantock:define_super_fund:cancellation:service_rights:0","event_type":"cancellation","exercise_price":null,"expiry_date":null,"holding_after":98889,"holding_before":296667,"interest_type":"indirect","notes":"","original_wording":"197,778 EL8AQ Service Rights ceased by lapse of conditional rights because conditions had not been met.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":197778,"quantity_acquired":0,"quantity_disposed":197778,"reconciliation_note":"The issuer-level 3H lapse is not individually attributed. The 2023 3Y identified 296,667 Service Rights in Bantock's Define Super Fund account; the 2025 annual report reports 98,889 remaining in the same account. The exact decrease is 197,778, matching the entire class lapse reported on 16 May 2025. This cross-source attribution does not imply an additional lapse.","reconciliation_status":"explained","security_class":"Service Rights","source_refs":[{"locator":"Appendix 3H, service rights ceased and reason","page":1,"source_id":"2924-02947537-6A1264894"},{"locator":"Andrew Bantock Appendix 3Y, 2023 grant to Define Super Fund","page":5,"source_id":"2924-02752572-6A1185915"},{"locator":"Annual report, director interests at 30 June 2025","page":76,"source_id":"2924-02995811-6A1284825"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":50000.275,"consideration_basis":"cash","consideration_details":"Placement subscription at $0.325 per share; amount calculated from disclosed price and shares (153,847 x $0.325).","contract_details":"","currency":"AUD","date":"2024-12-20","date_end":null,"economic_event_id":"2924-02897727-6A1244884:murray_hill:subscription:fully_paid_ordinary_shares:2:27","entity_id":"murray_hill","event_id":"2924-02897727-6A1244884:murray_hill:subscription:fully_paid_ordinary_shares:2:27","event_type":"subscription","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"153,847 ordinary shares subscribed for under placement at $0.325 per share.","percentage":null,"percentage_basis":null,"price":0.325,"price_basis":"disclosed","quantity":153847,"quantity_acquired":153847,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Part 1, number acquired/value/holding after","page":2,"source_id":"2924-02897727-6A1244884"}],"supersedes":[],"venue":"off_market","view":"directors"},{"account_entity_id":"define_super_fund","cash_amount":30000.1,"consideration_basis":"cash","consideration_details":"Placement subscription at $0.325 per share; amount calculated from disclosed price and shares (92,308 x $0.325).","contract_details":"","currency":"AUD","date":"2024-12-20","date_end":null,"economic_event_id":"2924-02897722-6A1244882:andrew_bantock:subscription:fully_paid_ordinary_shares:2:28","entity_id":"andrew_bantock","event_id":"2924-02897722-6A1244882:andrew_bantock:subscription:fully_paid_ordinary_shares:2:28","event_type":"subscription","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"92,308 ordinary shares issued to Define Consulting Pty Ltd ATF the Define Superannuation Fund under placement at $0.325 per share.","percentage":null,"percentage_basis":null,"price":0.325,"price_basis":"disclosed","quantity":92308,"quantity_acquired":92308,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Part 1, number acquired/value/registered holder","page":2,"source_id":"2924-02897722-6A1244882"}],"supersedes":[],"venue":"off_market","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Disclosed estimated value $0.43 per Service Right is not cash consideration.","contract_details":"","currency":"AUD","date":"2023-12-11","date_end":null,"economic_event_id":"2924-02752572-6A1185915:stephen_mann:grant:service_rights:3","entity_id":"stephen_mann","event_id":"2924-02752572-6A1185915:stephen_mann:grant:service_rights:3","event_type":"grant","exercise_price":null,"expiry_date":"2028-11-30","holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"130,000 Service Rights acquired by Stephen Mann, expiring 30 November 2028.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":130000,"quantity_acquired":130000,"quantity_disposed":0,"reconciliation_note":"","security_class":"Service Rights","source_refs":[{"locator":"Stephen Mann Appendix 3Y, number acquired","page":7,"source_id":"2924-02752572-6A1185915"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Disclosed estimated closing-share-price value $0.43 per right is not cash consideration.","contract_details":"The source wording's security class is inconsistent with the issuer's aggregate 3G counts and 2023 Disclosure Document.","currency":"AUD","date":"2023-12-11","date_end":null,"economic_event_id":"2924-02752572-6A1185915:murray_hill:grant:retention_rights:0","entity_id":"murray_hill","event_id":"2924-02752572-6A1185915:murray_hill:grant:retention_rights:0","event_type":"grant","exercise_price":null,"expiry_date":"2028-11-30","holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"440,089 Service Rights granted to Murray Philip Hill, expiring 30 November 2028.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":440089,"quantity_acquired":440089,"quantity_disposed":0,"reconciliation_note":"The 3Y labels 440,089 as Service Rights, but the 3G reports 426,667 service rights for directors and 830,011 retention rights. The 2023 Disclosure Document identifies Hill's 440,089 as Retention Rights; 426,667 equals Bantock's 296,667 plus Mann's 130,000 service rights, and 830,011 equals Hill's 440,089 plus McBride's 389,922 retention rights. Preserve the disclosed quantity and correct only its class.","reconciliation_status":"explained","security_class":"Retention Rights","source_refs":[{"locator":"Murray Hill Appendix 3Y, number acquired","page":2,"source_id":"2924-02752572-6A1185915"},{"locator":"Appendix 3G, aggregate director service-right issue","page":5,"source_id":"2924-02752565-6A1185907"},{"locator":"Appendix 3G, aggregate retention-right issue","page":7,"source_id":"2924-02752565-6A1185907"},{"locator":"Disclosure Document, director rights holdings","page":34,"source_id":"2924-02755397-6A1186983"}],"supersedes":["2924-02752572-6A1185915:murray_hill:grant:service_rights:0"],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Disclosed Black-Scholes value $0.3007 per option is not cash consideration.","contract_details":"","currency":"AUD","date":"2023-12-11","date_end":null,"economic_event_id":"2924-02752572-6A1185915:murray_hill:grant:options:1","entity_id":"murray_hill","event_id":"2924-02752572-6A1185915:murray_hill:grant:options:1","event_type":"grant","exercise_price":0.72,"expiry_date":"2026-11-30","holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"4,082,341 options granted to Murray Philip Hill, exercisable at $0.72 on or before 30 November 2026.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":4082341,"quantity_acquired":4082341,"quantity_disposed":0,"reconciliation_note":"","security_class":"Options","source_refs":[{"locator":"Murray Hill Appendix 3Y, number acquired","page":2,"source_id":"2924-02752572-6A1185915"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":"define_super_fund","cash_amount":null,"consideration_basis":"non_cash","consideration_details":"Disclosed estimated value $0.43 per Service Right is not cash consideration.","contract_details":"","currency":"AUD","date":"2023-12-11","date_end":null,"economic_event_id":"2924-02752572-6A1185915:andrew_bantock:grant:service_rights:2","entity_id":"andrew_bantock","event_id":"2924-02752572-6A1185915:andrew_bantock:grant:service_rights:2","event_type":"grant","exercise_price":null,"expiry_date":"2028-11-30","holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"296,667 Service Rights acquired by Define Consulting Pty Ltd ATF the Define Superannuation Fund, expiring 30 November 2028.","percentage":null,"percentage_basis":null,"price":null,"price_basis":"not_disclosed","quantity":296667,"quantity_acquired":296667,"quantity_disposed":0,"reconciliation_note":"","security_class":"Service Rights","source_refs":[{"locator":"Andrew Bantock Appendix 3Y, number acquired","page":5,"source_id":"2924-02752572-6A1185915"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":null,"consideration_basis":"non_cash","consideration_details":"262,153 shares non-cash-exercised; $0.17/share is disclosed for the resulting shares, not cash paid.","contract_details":"","currency":"AUD","date":"2023-11-27","date_end":null,"economic_event_id":"2924-02745977-6A1183092:andrew_bantock:exercise:fully_paid_ordinary_shares:1","entity_id":"andrew_bantock","event_id":"2924-02745977-6A1183092:andrew_bantock:exercise:fully_paid_ordinary_shares:1","event_type":"exercise","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"262,153 non-cash-exercised ordinary shares at the stated $0.17 per share.","percentage":null,"percentage_basis":null,"price":0.17,"price_basis":"disclosed","quantity":262153,"quantity_acquired":262153,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Andrew Bantock Appendix 3Y, number acquired/value","page":2,"source_id":"2924-02745977-6A1183092"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":102000,"consideration_basis":"cash","consideration_details":"600,000 shares cash-exercised at $0.17/share; cash consideration calculated from explicit cash exercise and price.","contract_details":"","currency":"AUD","date":"2023-11-27","date_end":null,"economic_event_id":"2924-02745977-6A1183092:andrew_bantock:exercise:fully_paid_ordinary_shares:0","entity_id":"andrew_bantock","event_id":"2924-02745977-6A1183092:andrew_bantock:exercise:fully_paid_ordinary_shares:0","event_type":"exercise","exercise_price":null,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"direct","notes":"","original_wording":"600,000 cash-exercised ordinary shares at $0.17 per share.","percentage":null,"percentage_basis":null,"price":0.17,"price_basis":"disclosed","quantity":600000,"quantity_acquired":600000,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Andrew Bantock Appendix 3Y, number acquired/value","page":2,"source_id":"2924-02745977-6A1183092"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":612000,"consideration_basis":"cash","consideration_details":"3,600,000 options exercised for cash at $0.17 per resulting ordinary share; cash total calculated from the disclosed per-share exercise amount.","contract_details":"","currency":"AUD","date":"2023-11-27","date_end":null,"economic_event_id":"2924-02745976-6A1183091:murray_hill:carol_hill:exercise:ordinary:0","entity_id":"carol_hill","event_id":"2924-02745976-6A1183091:murray_hill:carol_hill:exercise:ordinary:0","event_type":"exercise","exercise_price":0.17,"expiry_date":"2023-12-01","holding_after":7625873,"holding_before":4025873,"interest_type":"indirect","notes":"","original_wording":"Carol Ann Hill acquired 3,600,000 ordinary shares by cash exercise of options at $0.17 per share.","percentage":null,"percentage_basis":null,"price":0.17,"price_basis":"disclosed","quantity":3600000,"quantity_acquired":3600000,"quantity_disposed":0,"reconciliation_note":"","security_class":"Ordinary fully paid shares","source_refs":[{"locator":"Part 1, number acquired, consideration and nature of change","page":2,"source_id":"2924-02745976-6A1183091"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":null,"cash_amount":92105.3,"consideration_basis":"cash","consideration_details":"Options exercised into ordinary shares at disclosed $0.10/share; cash calculated from the disclosed exercise price.","contract_details":"","currency":"AUD","date":"2023-06-26","date_end":null,"economic_event_id":"2924-02679622-6A1155542:carol_hill:exercise:fully_paid_ordinary_shares:0","entity_id":"carol_hill","event_id":"2924-02679622-6A1155542:carol_hill:exercise:fully_paid_ordinary_shares:0","event_type":"exercise","exercise_price":0.1,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"921,053 ordinary shares issued on exercise of options at $0.10 per share in Carol Ann Hill account.","percentage":null,"percentage_basis":null,"price":0.1,"price_basis":"disclosed","quantity":921053,"quantity_acquired":921053,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Murray Hill Appendix 3Y, Carol Ann Hill indirect interest, acquired / holdings","page":2,"source_id":"2924-02679622-6A1155542"}],"supersedes":[],"venue":"not_disclosed","view":"directors"},{"account_entity_id":"define_super_fund","cash_amount":65789.5,"consideration_basis":"cash","consideration_details":"Options exercised into ordinary shares at disclosed $0.10/share; cash calculated from the disclosed exercise price.","contract_details":"","currency":"AUD","date":"2023-06-26","date_end":null,"economic_event_id":"2924-02679622-6A1155542:andrew_bantock:exercise:fully_paid_ordinary_shares:1","entity_id":"andrew_bantock","event_id":"2924-02679622-6A1155542:andrew_bantock:exercise:fully_paid_ordinary_shares:1","event_type":"exercise","exercise_price":0.1,"expiry_date":null,"holding_after":null,"holding_before":null,"interest_type":"indirect","notes":"","original_wording":"657,895 ordinary shares acquired by exercise of options at $0.10 per share in Define Superannuation Fund.","percentage":null,"percentage_basis":null,"price":0.1,"price_basis":"disclosed","quantity":657895,"quantity_acquired":657895,"quantity_disposed":0,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Andrew Bantock Appendix 3Y, Define Superannuation Fund number acquired","page":5,"source_id":"2924-02679622-6A1155542"}],"supersedes":[],"venue":"not_disclosed","view":"directors"}],"facets":{"entities":["andrew_bantock","carol_hill","murray_hill","carmu_super_fund","murray_carol_carmu_group","scott_perry","stephen_mann","tracy_mann"],"event_types":["cancellation","exercise","expiry","grant","purchase","subscription","transfer_in","transfer_out"],"securities":["2025 LTI Performance Rights","2025 STI Performance Rights","Fully paid ordinary shares","Options","Ordinary fully paid shares","Retention Rights","Service Options","Service Rights","Unlisted options exercisable at $0.61"]},"filters":{"end":"","entity":"","security":"","start":"","type":"","view":"directors"},"holdings":[],"pending_count":0,"pending_ownership_count":0,"pending_support_count":0,"review":{"coverage_note":"Reviewed and dispositioned the outstanding 52 documents in the refreshed 105-source EL8 index, plus re-reconciled Paradice's December 2024 substantial-holder entry against the placement release and issue filings. Named director transactions and holder allocations are retained only where source evidence identifies them.","coverage_start":"2023-01-01","cutoff_date":"2026-11-02","download_profile":"valuation","issuer_identifier":"ACN 001 666 600 / ABN 71 001 666 600","issuer_name":"Elevate Uranium Limited","limitations":["ASX and issuer disclosures do not establish complete non-director employee trading coverage.","Unnamed institutional placement recipients and issuer-wide option grants or expiries are not attributed to specific holders without an allocation disclosure.","A reported substantial-holder allocation percentage is not treated as a post-issue total holding unless the filing provides that position."],"reviewed_at":"2026-11-02T13:55:35Z","schema_version":"1.1.0","ticker":"EL8","view_coverage":{"directors":{"coverage_start":"2023-01-01","note":"All indexed substantive director notices and relevant meeting, grant, exercise, lapse, placement and annual-report context through 30 October 2026 were reviewed against the existing director rows. Director grants, exercises and lapses remain tied to named Appendix 3Y records; aggregate issuer issues are not assigned to a director without support.","reviewed_at":"2026-11-02T13:55:35Z","reviewed_through":"2026-10-30","status":"complete"},"major_holders":{"coverage_start":"2023-01-01","note":"All indexed substantial-holder notices and relevant placement, capital, meeting and annual-report sources through 30 October 2026 were reviewed. Paradice placement allocations are reconciled to its Form 604 and the 2024 and 2025 issuer filings; Cumulus allocations remain separate from issuer-wide option classes; unnamed placement subscriptions remain unallocated.","reviewed_at":"2026-11-02T13:55:35Z","reviewed_through":"2026-10-30","status":"complete"}}},"review_digest":"51ea88db951598bfb194a92cb5990561aef39cc104b0883e3b69cdb367ac3180","review_issues":[{"note":"The 3Y labels 440,089 as Service Rights, but the 3G reports 426,667 service rights for directors and 830,011 retention rights. The 2023 Disclosure Document identifies Hill's 440,089 as Retention Rights; 426,667 equals Bantock's 296,667 plus Mann's 130,000 service rights, and 830,011 equals Hill's 440,089 plus McBride's 389,922 retention rights. Preserve the disclosed quantity and correct only its class.","record_id":"2924-02752572-6A1185915:murray_hill:grant:retention_rights:0","source_ids":["2924-02752565-6A1185907","2924-02752572-6A1185915","2924-02755397-6A1186983"],"status":"explained","view":"directors"},{"note":"The issuer-level 3H lapse is not individually attributed. The 2023 3Y identified 296,667 Service Rights in Bantock's Define Super Fund account; the 2025 annual report reports 98,889 remaining in the same account. The exact decrease is 197,778, matching the entire class lapse reported on 16 May 2025. This cross-source attribution does not imply an additional lapse.","record_id":"2924-02947537-6A1264894:andrew_bantock:define_super_fund:cancellation:service_rights:0","source_ids":["2924-02752572-6A1185915","2924-02947537-6A1264894","2924-02995811-6A1284825"],"status":"explained","view":"directors"}],"scan":{"failures":[],"last_collected_at":"2026-11-06T12:03:41.748918Z","profile":"valuation","scanned_through":"2026-11-06","ticker":"EL8"},"sources":{"2924-02621872-6A1132065":{"category":"security_event","collected_at":"2026-10-09T18:27:59.513808Z","page_count":7,"published_at_utc":"2023-01-17T07:09:20.000Z","relative_path":"2023/2023-01-17_0347f9b505d6b8303c51c06f.pdf","review_note":"Reviewed all seven Appendix 3G pages. It reports 1,000,000 employee options exercisable at $0.65 through 16 January 2027 and explicitly says no KMP/associate recipient. The March 2024 Appendix 3H reports 330,000 lapses from this issuer-wide class; no director or substantial holder is named.","sha256":"7b9b36d657bcd6835b9001f5105aea31c28e7757119c93eafecd6eaafa3fb2c8","source_id":"2924-02621872-6A1132065","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"The source expressly excludes KMP/associates, and the related lapse is an employee class disclosure with no in-scope holder allocation.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02621872-6A1132065"},"2924-02679616-6A1155536":{"category":"security_event","collected_at":"2026-10-09T18:27:59.024308Z","page_count":6,"published_at_utc":"2023-06-26T06:48:58.000Z","relative_path":"2023/2023-06-26_b08745fa5df6200d151f6d1d.pdf","review_note":"Reviewed all six Appendix 2A pages. It confirms 2,368,422 ordinary shares issued 26 June 2023 at $0.10 from option exercise. Named director 3Ys account for 1,578,948 shares (Hill 921,053; Bantock 657,895); the 2023 annual report identifies another 263,158 for non-director CFO/Company Secretary McBride. The remaining 526,316 shares are an aggregate remainder, not attributable to a director or holder.","sha256":"c6f88af435bfb6fb177e4ed7e5d46c4cc3be47f56c62e4659e86e2dfdeb330c9","source_id":"2924-02679616-6A1155536","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The total supports director exercise reconciliation and issuer-share context; individual rows are recorded only for named 3Y recipients.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02679616-6A1155536"},"2924-02679622-6A1155542":{"category":"director_interest","collected_at":"2026-10-09T18:27:58.569212Z","page_count":6,"published_at_utc":"2023-06-26T06:57:28.000Z","relative_path":"2023/2023-06-26_f5ee1c6303a46ecc05131bde.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"2c50b7c00cf55871224c1c22c82a70a82e397751191337fcf9504e6701205671","source_id":"2924-02679622-6A1155542","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change in Director's Interest Notice X 2","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02679622-6A1155542"},"2924-02688268-6A1159052":{"category":"security_event","collected_at":"2026-10-09T18:27:55.872240Z","page_count":7,"published_at_utc":"2023-07-19T07:09:21.000Z","relative_path":"2023/2023-07-19_ec21fc1dcb1701886d72ad76.pdf","review_note":"Reviewed all seven Appendix 3G pages. The issuer granted 200,000 employee options exercisable at $0.45 through 18 July 2027 and explicitly reported no KMP/associate recipient; no director or substantial holder is named.","sha256":"b1af01a95f79d10be11353811f8b2e19390fdedff1c59584308c2f43b2a0f2f0","source_id":"2924-02688268-6A1159052","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"The filing expressly identifies a non-KMP employee option grant, outside both director and major-holder views.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02688268-6A1159052"},"2924-02715307-6A1169817":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:55.341694Z","page_count":1,"published_at_utc":"2023-09-22T06:34:36.000Z","relative_path":"2023/2023-09-22_60a96aebad28ae524bf25244.pdf","review_note":"Reviewed the one-page AGM-date notification. It gives only the future meeting date and does not describe securities or shareholder resolutions.","sha256":"3f72e686075c74a92c87bdc17c4421c89e5cb6d30f41914cfae961ec7ad2a296","source_id":"2924-02715307-6A1169817","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of Annual General Meeting Date","triage":{"classification":"background_only","reason":"Scheduling notice only; the later AGM notice contains the substantive matters.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02715307-6A1169817"},"2924-02717167-6A1170605":{"category":"shareholder_list","collected_at":"2026-10-09T18:27:54.117739Z","page_count":70,"published_at_utc":"2023-09-27T07:42:13.000Z","relative_path":"2023/2023-09-27_15a723ad1cc10d3cea043f2d.pdf","review_note":"Reviewed the directors' interest, KMP exercise/option and Additional ASX Information sections. Pages 27-28 reconcile aggregate director/KMP option exercises; pages 66-68 show the 31 August 2023 Top 20 and option-class holders, with no lodged substantial-holder notices reported. These dated tables are context and do not establish trades or current positions.","sha256":"e2f24f4942aecc596f2c531580a9dac3fa3fa5d2d5baf2ab248e0c4e233ffae5","source_id":"2924-02717167-6A1170605","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Annual Report to shareholders","triage":{"classification":"relevant","reason":"The report reconciles director exercise classes and confirms the dated registered-holder context, but is not a transaction notice or a substitute for substantial-holder disclosures.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02717167-6A1170605"},"2924-02726374-6A1174547":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:48.864963Z","page_count":1,"published_at_utc":"2023-10-17T06:10:14.000Z","relative_path":"2023/2023-10-17_de32e888b2984d4492e6512d.pdf","review_note":"Reviewed the one-page AGM notification letter. It only alerts holders to the separate AGM notice; it contains no transaction terms.","sha256":"2f77387d11e86bca8e6f2a04423821f7d7e315d8c6501e0a4c6806fae1804696","source_id":"2924-02726374-6A1174547","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"AGM NOM Notification Letter","triage":{"classification":"background_only","reason":"Administrative notice only; substantive resolutions are in the separately reviewed AGM materials.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02726374-6A1174547"},"2924-02726375-6A1174549":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:47.787391Z","page_count":59,"published_at_utc":"2023-10-17T06:11:34.000Z","relative_path":"2023/2023-10-17_256629061f9b803be8401ffb.pdf","review_note":"Reviewed all AGM resolution and explanatory pages. Resolutions 3-6 seek approval for named director service/retention rights and Murray Hill options, plus non-director company secretary Shane McBride's rights/options; later Appendix 3Ys/3Gs document actual director issues. Resolutions on the employee scheme and 10% placement capacity are context only; no holder allocation is named.","sha256":"655ba7c86438b83c9f9797bb8e53bbe98ac8fedd3c4a2f0ec39d7273fcaf5b11","source_id":"2924-02726375-6A1174549","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of Annual General Meeting/Proxy Form","triage":{"classification":"relevant","reason":"It identifies proposed director securities and capital capacity; the subsequent result and executed award filings were checked before classifying events.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02726375-6A1174549"},"2924-02745059-6A1182691":{"category":"meeting_result","collected_at":"2026-10-09T18:27:45.684038Z","page_count":2,"published_at_utc":"2023-11-24T04:33:39.000Z","relative_path":"2023/2023-11-24_4fc49083ca9a80a34ba4c30e.pdf","review_note":"Reviewed both results pages. The 2023 AGM resolutions passed, including approval of director service/retention rights and the employee incentive scheme and placement capacity; actual grants are captured from named 3Ys/3Gs, and no holder trade is reported.","sha256":"06124ead24191bdc00a4bd17a48de292bd6e57c278432b51cd6e9e26952d25a4","source_id":"2924-02745059-6A1182691","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Results of Meeting","triage":{"classification":"relevant","reason":"The results confirm approval context for actual director awards and issuer capital capacity, without recording any separate transaction.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02745059-6A1182691"},"2924-02745915-6A1183065":{"category":"security_event","collected_at":"2026-10-09T18:27:44.393331Z","page_count":6,"published_at_utc":"2023-11-27T07:50:37.000Z","relative_path":"2023/2023-11-27_4718c3722b963421e318fcd7.pdf","review_note":"Reviewed all six Appendix 2A pages. It confirms 1,572,917 ordinary shares issued on 27 November 2023 on a non-cash option conversion at the disclosed $0.17 reference price. The director 3Ys allocate 262,153 shares to Bantock; this aggregate form does not identify the remaining recipients.","sha256":"db386358e9c5d248a301d640622af6dd2b3243f0c09ece2997b114f0eca8bb5c","source_id":"2924-02745915-6A1183065","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed non-cash conversion supports named director exercise rows and class reconciliation but contains no substantial-holder allocation.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02745915-6A1183065"},"2924-02745917-6A1183066":{"category":"security_event","collected_at":"2026-10-09T18:27:43.861068Z","page_count":6,"published_at_utc":"2023-11-27T07:52:37.000Z","relative_path":"2023/2023-11-27_e5c48b76d0bfb9de468d5ab7.pdf","review_note":"Reviewed all six Appendix 2A pages. It confirms 5,200,000 ordinary shares issued on 27 November 2023 from cash exercise of $0.17 options. The matched director 3Ys record Hill's 3.6m and Bantock's 600k exercises; the residual issuer aggregate is not allocated to a named holder by this form.","sha256":"8292edc8bf692a8d9ba37a2e7421ce66de044857f0053a350f889d026277e30c","source_id":"2924-02745917-6A1183066","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The aggregate conversion provides share-issue context and corroborates named director exercise notices; it is not a holder transaction notice.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02745917-6A1183066"},"2924-02745919-6A1183068":{"category":"security_event","collected_at":"2026-10-09T18:27:43.317747Z","page_count":4,"published_at_utc":"2023-11-27T07:53:12.000Z","relative_path":"2023/2023-11-27_4468376a9d444b71bc23456c.pdf","review_note":"Reviewed all four Appendix 3H pages. Page 3 reports 827,083 EL8AD options expired on 27 November 2023 and states that 2,400,000 options had converted into 1,572,917 shares. The lapse plus conversion reconciles to the class; director exercises are captured in Appendix 3Ys, while remaining non-director portions are not attributed.","sha256":"65e449111f3e0fe3577bf1eace39b8a461273d692dba439bd235d173f782a255","source_id":"2924-02745919-6A1183068","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","triage":{"classification":"relevant","reason":"The issuer-wide option expiry reconciles with director cashless exercises and the related Appendix 2As; it does not disclose a substantial-holder allocation.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02745919-6A1183068"},"2924-02745976-6A1183091":{"category":"director_interest","collected_at":"2026-10-09T17:46:12.033894Z","page_count":3,"published_at_utc":"2023-11-27T21:15:11.000Z","relative_path":"2023/2023-11-28_Change of Director's Interest Notice - Murray Hill_17061535a542e567.pdf","review_note":"Reviewed all pages and annexures for issuer identity, transaction scope, class, date, and relevant account or security changes.","sha256":"a218f04fdb5f5ab1fa016525744dcff75b023f5da3aa503e366765161e095207","source_id":"2924-02745976-6A1183091","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice - Murray Hill","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02745976-6A1183091"},"2924-02745977-6A1183092":{"category":"director_interest","collected_at":"2026-10-09T18:27:42.821554Z","page_count":3,"published_at_utc":"2023-11-27T21:15:16.000Z","relative_path":"2023/2023-11-28_737c1939f6baa2d246f5a0d9_verified.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"ce4cafb75774efc9db1f4e29c1f1f01579e3fbb2138cbe8da4c0decaa3988aaa","source_id":"2924-02745977-6A1183092","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice - Andrew Bantock","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02745977-6A1183092"},"2924-02751733-6A1185515":{"category":"investment_release","collected_at":"2026-10-09T18:27:41.456818Z","page_count":4,"published_at_utc":"2023-12-07T22:58:59.000Z","relative_path":"2023/2023-12-08_4ebc7efc92bfbd5ddf6ebf92.pdf","review_note":"Reviewed all four pages. It announces $10m of binding placement commitments and 23,809,524 shares at $0.42, with Cumulus Wealth and Discovery as joint lead managers; it does not identify individual share subscriber allocations. The 3B and 2A give issue terms, and the later prospectus/3G evidence identifies Cumulus's 1.5m Broker Options separately.","sha256":"0fa8c14053794fe1306428c09f499c0e375627b203e0114fae148ad36f32d826","source_id":"2924-02751733-6A1185515","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"$10M Equity received to Accelerate Its Growth Strategy","triage":{"classification":"relevant","reason":"The release corroborates the placement and named manager relationship but does not support assigning shares to a substantial holder.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02751733-6A1185515"},"2924-02751734-6A1185522":{"category":"security_event","collected_at":"2026-10-09T18:27:40.110931Z","page_count":8,"published_at_utc":"2023-12-07T22:59:04.000Z","relative_path":"2023/2023-12-08_c8c402682688fec5961b137b.pdf","review_note":"Reviewed all eight Appendix 3B pages. It proposes 23,809,524 shares at $0.42, 11,904,762 one-for-two free-attaching $0.60 options, and 3,000,000 JLM options at the same exercise price. The December 15 Appendix 2A confirms the shares; the later 3G/prospectus identify Cumulus's 1.5m allocation within the JLM class, while no share purchaser allocation is disclosed here.","sha256":"2f0f3a3ce6b48018b18252aa78610ce247c45e95601321a0f5def4842074b154","source_id":"2924-02751734-6A1185522","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The proposal establishes placement and option-class terms used to reconcile the later Cumulus-specific broker-option event without attributing the rest of the class.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02751734-6A1185522"},"2924-02752565-6A1185907":{"category":"security_event","collected_at":"2026-10-09T18:27:39.551363Z","page_count":10,"published_at_utc":"2023-12-11T06:21:16Z","relative_path":"2023/2023-12-11_dbff27e6752bdbe4c33a6a2d.pdf","review_note":"Reviewed the complete Appendix 3G. Its aggregate issue is consistent with the related director notices after correcting Hill's 440,089 rights from Service Rights to Retention Rights; no separate individual event is added from this aggregate form.","sha256":"3e047aac2e53bcc7da223593c900d063ac3993848e0e6bcc0e3b272fc7d5252f","source_id":"2924-02752565-6A1185907","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02752565-6A1185907"},"2924-02752572-6A1185915":{"category":"director_interest","collected_at":"2026-10-09T18:27:39.040697Z","page_count":9,"published_at_utc":"2023-12-11T06:33:36Z","relative_path":"2023/2023-12-11_f48355d73fb35d48a4b10197_verified.pdf","review_note":"Re-reviewed the three Appendix 3Y notices and reconciled Hill's 440,089 award class against the issuer Appendix 3G, 2023 Disclosure Document and later annual report. Original quantity and wording are retained; class corrected from Service Rights to Retention Rights.","sha256":"ba676ad92a738de69c70247b89664d5daec317a2c2c21ed240e202c5ace9aae4","source_id":"2924-02752572-6A1185915","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice X 3","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02752572-6A1185915"},"2924-02754606-6A1186687":{"category":"security_event","collected_at":"2026-10-09T18:27:35.098639Z","page_count":6,"published_at_utc":"2023-12-15T01:17:52.000Z","relative_path":"2023/2023-12-15_9895b3d1b607af03b53c78fe.pdf","review_note":"Reviewed all six Appendix 2A pages. It confirms 23,809,524 ordinary placement shares issued on 15 December 2023 at $0.42; attaching options were to follow under a prospectus. The later Appendix 3G and prospectus evidence support the separate Cumulus JLM-option allocation; this 2A does not name share subscribers.","sha256":"f625885a95b7c5b53a2817d6ea02fc38230ad48f07eb2ab2a85a8ca40e23f894","source_id":"2924-02754606-6A1186687","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed share issue supports issuer-capital and placement context; no individual holder allocation is inferred from the aggregate form.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02754606-6A1186687"},"2924-02755397-6A1186983":{"category":"investment_release","collected_at":"2026-10-09T18:27:34.561660Z","page_count":41,"published_at_utc":"2023-12-18T05:26:26Z","relative_path":"2023/2023-12-18_73803045efb49f87eeab3a8f.pdf","review_note":"Reviewed the 2023 placement Disclosure Document. Page 6 allocates 1,500,000 Broker Options to Cumulus Wealth or nominee; page 34 identifies Hill's 440,089 Retention Rights and the Bantock/Mann Service Rights; page 36 separately confirms the Cumulus allocation and fair value.","sha256":"8ded5a0d0e73cf1bd186b10b2f3a2a8114d892404501f4c3825ebb98e82f6949","source_id":"2924-02755397-6A1186983","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Disclosure Document","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02755397-6A1186983"},"2924-02756562-6A1187427":{"category":"holder_notice","collected_at":"2026-10-09T18:27:29.770316Z","page_count":5,"published_at_utc":"2023-12-20T06:01:50.000Z","relative_path":"2023/2023-12-20_8bb12d41fba8ad6a9f63e821_verified.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"8f2c00e2c7b901b2f161fda022079134cded45607644ba6f6f3b878087a17c46","source_id":"2924-02756562-6A1187427","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Becoming a substantial holder","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02756562-6A1187427"},"2924-02756615-6A1187448":{"category":"security_event","collected_at":"2026-10-09T18:27:30.308029Z","page_count":8,"published_at_utc":"2023-12-20T07:41:01Z","relative_path":"2023/2023-12-20_4d169248c04ee733f4dfce6d.pdf","review_note":"Reviewed the complete Appendix 3G. The 3,000,000 Broker Options include Cumulus Wealth's separately allocated 1,500,000 options in the 2023 placement Disclosure Document; only the in-scope holder allocation is recorded. The 11,904,798 Placement Options are not attributed to named holders.","sha256":"a37c482d1622bb2cc34b165fd54f4dafdcbd7688f742f85dbf0074818994ba12","source_id":"2924-02756615-6A1187448","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02756615-6A1187448"},"2924-02768945-6A1192526":{"category":"holder_notice","collected_at":"2026-10-09T17:46:12.007789Z","page_count":3,"published_at_utc":"2024-02-02T05:49:32.000Z","relative_path":"2024/2024-02-02_Ceasing to be a substantial holder_af9304987fe4a55a.pdf","review_note":"Reviewed all pages and annexures for issuer identity, transaction scope, class, date, and relevant account or security changes. Currency-quality audit: the notice uses $ without explicitly identifying currency; previous assumed AUD cash and calculated prices are withheld, with source figures preserved in evidence details.","sha256":"a1708c5954d18c6927a4c9eaec3db5dcc0493671449efff03e37c7195ff763ca","source_id":"2924-02768945-6A1192526","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Ceasing to be a substantial holder","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02768945-6A1192526"},"2924-02780254-6A1196457":{"category":"security_event","collected_at":"2026-10-09T18:27:28.785729Z","page_count":4,"published_at_utc":"2024-03-01T01:57:15.000Z","relative_path":"2024/2024-03-01_5f65d9e5e629ae02f58b5d6e.pdf","review_note":"Reviewed all four Appendix 3H pages. It reports 330,000 of the 1,000,000 EL8AI employee options lapsed on 28 February 2024 after cessation of employment; the original 2023 3G states no KMP/associate received that grant. The remaining issuer class is 670,000; no director or substantial holder is named.","sha256":"9512e8e22ae8d7fec6fd0406aa9287f41d50516194fc8677463faa6f32cc61bb","source_id":"2924-02780254-6A1196457","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","triage":{"classification":"background_only","reason":"The cessation and original grant disclosures identify only a non-KMP employee option class; it does not affect director or substantial-holder coverage.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02780254-6A1196457"},"2924-02786235-6A1198895":{"category":"security_event","collected_at":"2026-10-09T18:27:28.263338Z","page_count":6,"published_at_utc":"2024-03-18T05:58:26.000Z","relative_path":"2024/2024-03-18_207846bc0451f53800b996f0.pdf","review_note":"Reviewed all six Appendix 3G pages. It issues 1,500,000 employee options at $0.75, expiring 26 February 2028, and reports no KMP/associate recipient; no director or substantial holder is identified.","sha256":"bebddda9ca09c6c0ee25fc64b79464b1f6c53f58b49616d4a959a85adc50da8f","source_id":"2924-02786235-6A1198895","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"No named director or substantial-holder allocation is disclosed, and the form explicitly says no KMP/associate received the grant.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02786235-6A1198895"},"2924-02823218-6A1213913":{"category":"security_event","collected_at":"2026-10-09T18:27:27.782059Z","page_count":6,"published_at_utc":"2024-07-01T06:34:46.000Z","relative_path":"2024/2024-07-01_8cdde3eb5abb9550be61213d.pdf","review_note":"Reviewed all six Appendix 3G pages. The notice issues 200,000 employee options with $0.70 exercise price and 30 June 2028 expiry, and says no KMP/associate receives them. It names no substantial holder or director.","sha256":"f45c28bdbaedc604388597d27ff321370060118200858922bf21176657443144","source_id":"2924-02823218-6A1213913","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"The issuer explicitly reports no KMP/associate allocation, and the grant is not attributed to a substantial holder.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02823218-6A1213913"},"2924-02837785-6A1220267":{"category":"holder_notice","collected_at":"2026-10-09T18:27:27.286053Z","page_count":6,"published_at_utc":"2024-08-12T08:37:46.000Z","relative_path":"2024/2024-08-12_22140a0569ce16e437fade29_verified.pdf","review_note":"All six pages read. The image-only page 3 annexure contains 55 individually reported Cumulus MDA client changes: sales, buys and new MDA accounts. Each row was visually checked and aligned with extracted date, amount, securities and votes; repeated-looking rows are retained. Dollar amounts do not explicitly identify currency. Pages 4\u20136 contain supplied MDA terms labelled pages 5\u20137, beginning at clause 3.3; earlier agreement pages are not present in this filing. The initial 15,717,577-share aggregate is not treated as a purchase or as an opening position.","sha256":"afb8d79bf764520fe40083b74374801e33160a6ffbca19e3ba7e525855b93e35","source_id":"2924-02837785-6A1220267","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Becoming a substantial holder","triage":{"classification":"relevant","reason":"Substantive initial-holder filing, individual changes and provided MDA agreement excerpt reviewed; currency and earlier agreement sections remain unspecified.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02837785-6A1220267"},"2924-02850608-6A1224562":{"category":"security_event","collected_at":"2026-10-09T18:27:26.261811Z","page_count":6,"published_at_utc":"2024-09-09T07:39:37.000Z","relative_path":"2024/2024-09-09_d7eafa515d9f498837dd10ce.pdf","review_note":"Reviewed all six Appendix 3G pages. It reports 210,000 employee options at $0.50, expiring 8 September 2028, and explicitly answers no for KMP/associate recipients; the 2024 annual report confirms the aggregate post-year-end issue. No director or substantial holder is named.","sha256":"ce2ecabace8fc4abe03d85d7cc9c7c7fa9a3c355fb0a8265c154c09c4df4c990","source_id":"2924-02850608-6A1224562","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"The filing expressly excludes KMP/associates and names no substantial holder; the employee grant does not affect either requested view.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02850608-6A1224562"},"2924-02855556-6A1226473":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:25.761408Z","page_count":1,"published_at_utc":"2024-09-20T08:19:29.000Z","relative_path":"2024/2024-09-20_89343f5f207ba09546802971.pdf","review_note":"Reviewed the one-page notice of the 2024 AGM date. It is scheduling information only and discloses no award or holder transaction.","sha256":"7fbfaf092e2998741eb40fb212932af8cc87bd7f69d40efcf2226fc246f61ed8","source_id":"2924-02855556-6A1226473","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of Annual General Meeting Date","triage":{"classification":"background_only","reason":"Administrative meeting-date notice only; resolutions appear in the subsequently reviewed AGM notice.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02855556-6A1226473"},"2924-02858909-6A1227912":{"category":"shareholder_list","collected_at":"2026-10-09T18:27:23.833724Z","page_count":72,"published_at_utc":"2024-09-27T07:12:22.000Z","relative_path":"2024/2024-09-27_d390d55d4f8172f028e25156.pdf","review_note":"Reviewed director-interest, KMP option/rights, additional ASX information and top-20 pages. Pages 22-29 disclose director/KMP positions and exercise/vesting totals reconciled to 3Y notices; pages 66-68 give a dated 4 September 2024 top-20 and identify Cumulus Wealth's 15,717,577 shares/5.10% as a notified substantial holder. These are dated context, not new trades or current balances.","sha256":"028de9c1adc1709318018916177db5e6931078b257e0ce80e73c438f19b5f230","source_id":"2924-02858909-6A1227912","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Annual Report to shareholders","triage":{"classification":"relevant","reason":"The report provides dated director security reconciliation and corroborates Cumulus's in-scope threshold position, without substituting annual balances for filed transaction notices.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02858909-6A1227912"},"2924-02867751-6A1231616":{"category":"holder_notice","collected_at":"2026-10-09T18:27:12.386960Z","page_count":18,"published_at_utc":"2024-10-16T23:25:40.000Z","relative_path":"2024/2024-10-17_041b7b70d20183e1372f8cf9.pdf","review_note":"Reviewed Form 604 pages 1\u20132 and all 15 scanned Annexure A pages (PDF pages 3\u201317), visually inspecting every row. Transcribed all 417 in-window SAM USA on-market trades dated 4 January 2023 through 30 September 2024, retaining duplicate same-day/same-price lines as distinct trades; pre-2023 Annexure rows excluded from the event window. Annexure B lists the controlled group; page 1 reports 26,188,907 shares / 8.49% as of 30 September 2024. Currency/consideration audit: the annexure labels its numerical figures only as consideration, without a currency or per-unit basis; previously inferred AUD prices and calculated cash have been withheld while source figures and transaction details remain.","sha256":"86a159d5e1408dd7b712f8fc2f415d24a1dea0a95dc8582f46f52b62e8a18b9b","source_id":"2924-02867751-6A1231616","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change in substantial holding","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02867751-6A1231616"},"2924-02869629-6A1232457":{"category":"investment_release","collected_at":"2026-10-09T18:27:10.986473Z","page_count":4,"published_at_utc":"2024-10-21T22:36:31.000Z","relative_path":"2024/2024-10-22_152ad0aff2f8ad450457664b.pdf","review_note":"Reviewed all four release pages. Pages 1-2 state Paradice Investment Management committed to subscribe for new shares at $0.325, targeting approximately $12.4m and a 9.9% pro-forma holding. The Form 604 annexure gives two dated allocations of 16,091,913 and 22,060,047 shares, which sum to its 38,151,960 threshold position; together with the tranche 1/tranche 2 issue filings, this resolves both allocations as placement subscriptions. Exact gross cash is calculated at $0.325 per share and attached to the reviewed Form 604 rows.","sha256":"984e3956d47ac77d6e1771710b86ad32f2dbbc6bb4301f98a901f45c9d285057","source_id":"2924-02869629-6A1232457","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Strongly supported $25M Institutional Placement","triage":{"classification":"relevant","reason":"It identifies Paradice as a placement subscriber; its dated allocation quantities and issue dates in the Form 604 tie to the two actual issue tranches, allowing the holder rows to be classified as subscriptions at the disclosed issue price.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02869629-6A1232457"},"2924-02869631-6A1232458":{"category":"security_event","collected_at":"2026-10-09T18:27:09.616965Z","page_count":5,"published_at_utc":"2024-10-21T22:36:56.000Z","relative_path":"2024/2024-10-22_4c55837c84fe1fd0c4c7bfe9.pdf","review_note":"Reviewed all five pages. This is the 32,444,977-share tranche-1 proposal at $0.325, divided between 15% capacity (27,790,796) and 10% capacity (4,654,181). It does not disclose a named holder allocation.","sha256":"95c2c19a0d49c491fab60a02784e574d19273c552a22dc2d6182da3b671b5e57","source_id":"2924-02869631-6A1232458","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"It documents the completed placement tranche and its capacity basis; no holder event is allocated without a named allocation source.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02869631-6A1232458"},"2924-02869633-6A1232466":{"category":"security_event","collected_at":"2026-10-09T18:27:09.132670Z","page_count":5,"published_at_utc":"2024-10-21T22:37:11.000Z","relative_path":"2024/2024-10-22_1be25a1d9cbca699a0a3f792.pdf","review_note":"Reviewed all five pages. It proposes issue of 44,724,255 tranche-2 shares at $0.325; listing-rule 10.11 director participation is marked yes. Later issue/3Y filings establish execution and the 246,155 combined Hill/Bantock subscriptions.","sha256":"810fd60e68264e909ebf8123f84f3eb6779d0bbeefb14487966658b52b3f86a5","source_id":"2924-02869633-6A1232466","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The placement issue includes named director participation, later recorded from direct director notices; the remainder is not allocated to holders here.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02869633-6A1232466"},"2924-02869636-6A1232471":{"category":"security_event","collected_at":"2026-10-09T18:27:08.640887Z","page_count":5,"published_at_utc":"2024-10-21T22:37:26.000Z","relative_path":"2024/2024-10-22_5dd03a8cfef58ad574d49938.pdf","review_note":"Reviewed all five pages. It proposes 3,000,000 JLM options exercisable at $0.80 through 12 December 2026 for a $0.00001 issue price, conditional on the combined tranches raising over $15m. The later 3G identifies Cumulus Wealth's 1,000,000-option allocation; no balance of the aggregate 3m is attributed to a manager here.","sha256":"63bd54d2a38ddf3e62cef5aa039647acc6853876b0d00ab1519eed3e6cbee3f0","source_id":"2924-02869636-6A1232471","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The aggregate broker option terms support the later Cumulus-specific event while the remaining manager allocation is not disclosed in this source.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02869636-6A1232471"},"2924-02869918-6A1232607":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:08.060009Z","page_count":26,"published_at_utc":"2024-10-22T06:18:53.000Z","relative_path":"2024/2024-10-22_faa26dbc1d54b782433e9590.pdf","review_note":"Reviewed the full AGM notice and explanatory statement. It proposes approval of the 2024 placement tranches/JLM options and includes board remuneration and re-election resolutions. The 2024 placements are evidenced by subsequent 2A filings; director subscriptions are separately disclosed and captured in Appendix 3Y notices.","sha256":"6a58023af374c22a97b03acde0bf2a1e3e5812c4383a201ed67c14fe511aa3fe","source_id":"2924-02869918-6A1232607","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of Annual General Meeting/Proxy Form","triage":{"classification":"relevant","reason":"The notice frames proposed placement approvals and director-related resolutions; no proposed securities are treated as executed transactions.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02869918-6A1232607"},"2924-02869920-6A1232608":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:06.645466Z","page_count":1,"published_at_utc":"2024-10-22T06:19:28.000Z","relative_path":"2024/2024-10-22_a2bc0077407e3688aecc15e3.pdf","review_note":"Reviewed the one-page AGM notification letter. It announces distribution of the notice and contains no transaction particulars.","sha256":"9a8d37f2271c5eb1cd0e1f94e294563f5f32b7a81ddffbc46a7018454aa80db8","source_id":"2924-02869920-6A1232608","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"AGM Notification Letter","triage":{"classification":"background_only","reason":"Administrative shareholder-meeting notice only; the substantive resolutions are in the AGM notice.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02869920-6A1232608"},"2924-02874975-6A1235131":{"category":"security_event","collected_at":"2026-10-09T18:27:05.715509Z","page_count":7,"published_at_utc":"2024-10-30T22:49:05.000Z","relative_path":"2024/2024-10-31_d53a935a576bc7e29f591a15.pdf","review_note":"Reviewed all Appendix 2A pages. It confirms 32,444,977 ordinary placement shares issued 30 October 2024 at $0.325 and the updated issued capital; it does not name subscribers or allocate shares to substantial holders.","sha256":"9d32e2eccd40e5f013221c8ffcf3192d0af117cf6500c3b831872f45a24da00a","source_id":"2924-02874975-6A1235131","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed tranche supplies aggregate issuer-share count and price for placement reconciliation; no individual allocation is inferred.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02874975-6A1235131"},"2924-02876248-6A1235772":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:05.160561Z","page_count":4,"published_at_utc":"2024-11-01T06:09:59.000Z","relative_path":"2024/2024-11-01_dcc20be4abe2ec09f33b2bb1.pdf","review_note":"Reviewed all four pages. It updates the 2024 10% placement-capacity disclosure for the October placement and reports no related party, KMP, substantial holder, advisor or associate received more than 1% of the post-issue capital from the 4,654,181-share 10% tranche. The 246,155 Hill/Bantock shares in tranche 2 were subject to shareholder approval and are captured by their later Appendix 3Ys.","sha256":"354bd78de25f85d8dfc8648c076dbd104124b152dd60418321b982a9a1762f1b","source_id":"2924-02876248-6A1235772","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"ADDENDUM TO NOTICE OF GENERAL MEETING","triage":{"classification":"relevant","reason":"It separates the 10% tranche from named director subscriptions and limits holder attribution for the aggregate placement.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02876248-6A1235772"},"2924-02876249-6A1235775":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:04.015650Z","page_count":1,"published_at_utc":"2024-11-01T06:11:24.000Z","relative_path":"2024/2024-11-01_e1163fad252b680b7378ca8c.pdf","review_note":"Reviewed the one-page addendum notification letter. The transaction-relevant placement-capacity disclosure is in the associated four-page addendum.","sha256":"1c73e21828fb219b2faecd7ac5143d8c9e630ddbdc48bb3a2b94872f05e182f6","source_id":"2924-02876249-6A1235775","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"AGM Addendum Letter Notification","triage":{"classification":"background_only","reason":"Administrative notice of supplemental meeting material only.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02876249-6A1235775"},"2924-02878344-6A1236667":{"category":"holder_notice","collected_at":"2026-10-09T18:27:02.674631Z","page_count":3,"published_at_utc":"2024-11-07T09:02:15.000Z","relative_path":"2024/2024-11-07_a2a1a4d00e260c5a573993ea_verified.pdf","review_note":"Reviewed all three pages, including visually inspecting and transcribing the entire image-only 32-row Annexure 1. It reports one 34,500-share on-market buy and 31 separately listed placements by MDA clients, with repeated-looking rows retained as individually reported. The notice says substantial-holder status ceased on 28 October 2024 but reports no remaining position; cessation is not treated as a sale to zero. Dollar-denominated considerations are printed without an explicit currency.","sha256":"61e6ec67b0822f0bdc6a4e018e90e4a1c41a3efcd19e7fc6ac38b10b835f6b19","source_id":"2924-02878344-6A1236667","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Ceasing to be a substantial shareholder","triage":{"classification":"relevant","reason":"Substantive holder notice and transaction annexure reviewed; currency and post-cessation balance remain unspecified.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02878344-6A1236667"},"2924-02879779-6A1237184":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:01.508383Z","page_count":18,"published_at_utc":"2024-11-12T06:41:03Z","relative_path":"2024/2024-11-12_2961f96fbb26925959e8479a.pdf","review_note":"Reviewed the full notice, resolutions and proxy form. The proposed joint lead manager allocation identifies 1,000,000 options for Cumulus Wealth; the proposed issue is not treated as an event before the later Appendix 3G confirms issue.","sha256":"1bb81022d46b711d82232d7b8e6df7eddd4c5f2ac04581d31f32eeca43b9b286","source_id":"2924-02879779-6A1237184","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of General Meeting/Proxy Form","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02879779-6A1237184"},"2924-02879782-6A1237187":{"category":"meeting_notice","collected_at":"2026-10-09T18:27:00.142814Z","page_count":1,"published_at_utc":"2024-11-12T06:43:13.000Z","relative_path":"2024/2024-11-12_bf3f71b4fdf4ada8b8fcb68a.pdf","review_note":"Reviewed the one-page EGM notification letter. It directs shareholders to the meeting material but supplies no independent security terms or holder allocations.","sha256":"80962266e2fbec9259b532ffdebfb60de5667ece4686ca7ba9e94eed5ce64e1f","source_id":"2924-02879782-6A1237187","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"EGM NOM Notification Letter","triage":{"classification":"background_only","reason":"Administrative notification only; substantive EGM matters are in the separately reviewed meeting notice.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02879782-6A1237187"},"2924-02879803-6A1237204":{"category":"security_event","collected_at":"2026-10-09T18:26:58.925931Z","page_count":5,"published_at_utc":"2024-11-12T07:45:03.000Z","relative_path":"2024/2024-11-12_c7d84531a3676f45e993dec8.pdf","review_note":"Reviewed all five pages. The update sets 12 December as the meeting date for the 44,724,255-share tranche-2 placement at $0.325; later Appendix 2A confirms the issue and director filings identify the 246,155-share Hill/Bantock participation.","sha256":"f9ddf38c317fec49238f2b25f7c4360883ac5a0fa5eaf4c37bdda736e070fb81","source_id":"2924-02879803-6A1237204","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"It links the approved placement to the executed issue and named director subscriptions already captured separately.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02879803-6A1237204"},"2924-02879809-6A1237209":{"category":"security_event","collected_at":"2026-10-09T18:26:58.420510Z","page_count":5,"published_at_utc":"2024-11-12T07:48:43.000Z","relative_path":"2024/2024-11-12_f46eda8f2d8aa7cc6e71deca.pdf","review_note":"Reviewed all five pages. This update supplies a 12 December meeting date for the proposed 3,000,000 JLM options; the later 12 December update confirms approval, and a subsequent 3G reports the actual issue and Cumulus's specific allocation.","sha256":"0e44ae70edd10372528f8b7b8193de6d308396d727385dc198c4bcba6d64aa8b","source_id":"2924-02879809-6A1237209","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"It provides approval timing for the JLM option context; no individual manager allocation is inferred from the aggregate proposal.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02879809-6A1237209"},"2924-02888352-6A1240800":{"category":"meeting_result","collected_at":"2026-10-09T18:26:57.896503Z","page_count":2,"published_at_utc":"2024-11-29T04:21:06.000Z","relative_path":"2024/2024-11-29_2e8497cb9e88445710ba7777.pdf","review_note":"Reviewed both meeting-result pages. The 2024 AGM resolutions passed; results confirm approval context for the placement-capacity resolution and are not an executed director or holder transaction.","sha256":"f4ad9de7ffa557348b56ce79791f1612c9252543a945a755e5d4f7d37f4be538","source_id":"2924-02888352-6A1240800","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Results of Meeting","triage":{"classification":"relevant","reason":"The result establishes shareholder approval of capital capacity; actual placement issues and named allocations are recorded from the relevant issue/holder filings.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02888352-6A1240800"},"2924-02894090-6A1243325":{"category":"meeting_result","collected_at":"2026-10-09T18:26:56.595816Z","page_count":2,"published_at_utc":"2024-12-12T07:12:18Z","relative_path":"2024/2024-12-12_0443a2651a2369ae4f6b0f0d.pdf","review_note":"Reviewed the 12 December 2024 meeting results; relevant resolutions passed, including the joint lead manager option issue. The later Appendix 3G is the actual issue evidence.","sha256":"15159cf35d6085db578abcb20f12cc937ebedf999e983c68af4aa3a18458b40a","source_id":"2924-02894090-6A1243325","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Results of Meeting","triage":{"classification":"relevant","reason":"The result supplies approval context for the subsequent option issue and other capital actions, but reports no holder transaction or director trade.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02894090-6A1243325"},"2924-02894094-6A1243329":{"category":"security_event","collected_at":"2026-10-09T18:26:55.184777Z","page_count":5,"published_at_utc":"2024-12-12T07:22:08.000Z","relative_path":"2024/2024-12-12_9244dd24b8508407079ef133.pdf","review_note":"Reviewed all five pages. It confirms approval for tranche 2 of 44,724,255 shares at $0.325, due 20 December 2024; listing-rule 10.11 participation is reported. The later Appendix 2A confirms issuance, and director notices capture Hill/Bantock's 246,155-share participation.","sha256":"db0e4fc6edd73d1c008a3534bd09e9cd4eecb6621e505a793b57dee3c21e9b80","source_id":"2924-02894094-6A1243329","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The update provides placement terms and approval context for the issue that includes director subscriptions already captured in their Appendix 3Y notices.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02894094-6A1243329"},"2924-02894102-6A1243338":{"category":"security_event","collected_at":"2026-10-09T18:26:54.628871Z","page_count":5,"published_at_utc":"2024-12-12T07:34:23.000Z","relative_path":"2024/2024-12-12_fabb52191e853e4b15ef1de7.pdf","review_note":"Reviewed all five pages. The update records approval of the 3,000,000 JLM options proposed at $0.80 exercise, $0.00001 issue price and 12 December 2026 expiry; the 2025 Appendix 3G records actual issue and the individually disclosed Cumulus allocation. No director received these options.","sha256":"4e77117b13313bcf2a9358506fdae15d590f6c7591f91c24fe9dce8c61f47f56","source_id":"2924-02894102-6A1243338","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The aggregate fee-option approval is relevant to the later holder-specific Cumulus allocation, but the 3B itself does not allocate the remaining options among managers.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02894102-6A1243338"},"2924-02897604-6A1244837":{"category":"security_event","collected_at":"2026-10-09T18:26:54.098693Z","page_count":7,"published_at_utc":"2024-12-20T01:40:26.000Z","relative_path":"2024/2024-12-20_33f96666521cee5f6527dd94.pdf","review_note":"Reviewed all seven Appendix 2A pages. Pages 1 and 5-6 confirm 44,724,255 ordinary shares issued on 20 December 2024 at $0.325 and post-issue capital of 385,615,812; the separate 3Ys identify Hill and Bantock's 246,155-share director participation. Paradice's separately reported 22,060,047-share allocation is matched from its Form 604 to this tranche.","sha256":"774d4e25e32c6096882becaeef17ba2be26b315e718f581d975a0ec2cfd27a3c","source_id":"2924-02897604-6A1244837","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed tranche is the execution evidence for named director subscriptions and Paradice's subscribed allocation; no unnamed allocation is inferred.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02897604-6A1244837"},"2924-02897694-6A1244873":{"category":"security_event","collected_at":"2026-10-09T18:26:53.553441Z","page_count":8,"published_at_utc":"2024-12-20T03:49:41Z","relative_path":"2024/2024-12-20_961b72f1cb7fe2634f0314de.pdf","review_note":"Reviewed the complete Appendix 3G. It confirms 1,000,000 joint lead manager options to Cumulus Wealth on 20 December 2024 for AUD 0.00001 each, exercisable at AUD 0.80 and expiring 20 December 2026.","sha256":"e878684a67540bd97038f09794a4c4a0230d6ba5a491d0eb9837e6f4a76aabbe","source_id":"2924-02897694-6A1244873","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02897694-6A1244873"},"2924-02897722-6A1244882":{"category":"director_interest","collected_at":"2026-10-09T18:26:52.827597Z","page_count":3,"published_at_utc":"2024-12-20T04:07:01.000Z","relative_path":"2024/2024-12-20_7397fbe7dc983b5f306322e3.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"fa4289e2ae1719eb4e2cb7d073a9fa282db28f814a841c09151ceddfc981240d","source_id":"2924-02897722-6A1244882","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice - Andrew Bantock","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02897722-6A1244882"},"2924-02897727-6A1244884":{"category":"director_interest","collected_at":"2026-10-09T18:26:51.309097Z","page_count":4,"published_at_utc":"2024-12-20T04:08:21.000Z","relative_path":"2024/2024-12-20_29c45d1343c569c5b5b07bfc_verified.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"a00540eff543c9a15507d895993bb158ab933aefe029cca8e8487cb96a78ee74","source_id":"2924-02897727-6A1244884","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice - Murray Hill","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02897727-6A1244884"},"2924-02898912-6A1245388":{"category":"holder_notice","collected_at":"2026-10-09T18:26:49.667235Z","page_count":4,"published_at_utc":"2024-12-24T03:27:14.000Z","relative_path":"2024/2024-12-24_5afa13ec30ea8c54b6e7bd54_verified.pdf","review_note":"Re-reviewed all four pages, including the rotated page 3 annexure. The initial 38,151,960-share 9.89% position for Paradice Investment Management Pty Ltd/David Paradice is registered through HSBC Nominees. Annexure 1 lists 16,091,913 shares on 31 October and 22,060,047 on 20 December, summing to that initial position. The 22 October issuer release identifies Paradice as subscribing for placement shares; the two 3Bs and 2As confirm matching tranche dates, cash issue price of $0.325 and completed issues. The negative consideration values printed in the form are not treated as proof of direction; gross cash is calculated per tranche at the disclosed price, rounded to cents.","sha256":"6d39bc9cb1290c753f54727c916d3503fb87e84e930ed9fbf0a1e7f52b6f9a15","source_id":"2924-02898912-6A1245388","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Becoming a substantial holder","triage":{"classification":"relevant","reason":"This substantive initial-holder notice provides dated share quantities and account identity; the issuer's placement disclosures establish that both entries were subscriptions.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02898912-6A1245388"},"2924-02921387-6A1254247":{"category":"holder_notice","collected_at":"2026-10-09T18:26:48.927119Z","page_count":3,"published_at_utc":"2025-03-05T03:39:29.000Z","relative_path":"2025/2025-03-05_5475cc30de0a44f646281e05_verified.pdf","review_note":"Issuer and complete Form 603 pages reviewed. Transcribed all 74 Annexure 1 rows on page 3 individually: 43 placement allocations, 27 on-market buys, 1 on-market sale, and 3 new MDA account relevant-interest changes. The 3 account rows are contract/context changes, not trades. Threshold observation cites page 1. Currency-quality audit: the notice uses $ without explicitly identifying currency; previous assumed AUD cash and calculated prices are withheld, with source figures preserved in evidence details.","sha256":"bf49524a54e8f63720ace4d22a860638d82a76aaf96485ce689003ad896c31c5","source_id":"2924-02921387-6A1254247","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Becoming a substantial holder","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02921387-6A1254247"},"2924-02929413-6A1257492":{"category":"director_interest","collected_at":"2026-10-09T18:26:48.296226Z","page_count":2,"published_at_utc":"2025-03-27T02:21:52.000Z","relative_path":"2025/2025-03-27_98e67919d437b5523bf615fe.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"34cfa4d2254d83d0416160acf8369dbb3b6497a7174c17b050973c05ba20d987","source_id":"2924-02929413-6A1257492","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Final Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02929413-6A1257492"},"2924-02929414-6A1257493":{"category":"director_interest","collected_at":"2026-10-09T18:26:46.168216Z","page_count":2,"published_at_utc":"2025-03-27T02:22:52.000Z","relative_path":"2025/2025-03-27_3567d91a7083c598ee82f498_verified.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"dfc22079c6785d8ab93e5b2608bda96f3605569392df85c88940db1aba81ea8c","source_id":"2924-02929414-6A1257493","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Initial Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02929414-6A1257493"},"2924-02938608-6A1261068":{"category":"holder_notice","collected_at":"2026-10-09T18:26:44.334635Z","page_count":5,"published_at_utc":"2025-04-22T23:43:11.000Z","relative_path":"2025/2025-04-23_7240c69e9b54df859539f993_verified.pdf","review_note":"Reviewed all five original scanned pages, including each of 67 Annexure A rows and the group entities in Annexure B. The net increase of 15,811,083 shares equals the reported change from 26,188,907 to 41,999,990. Consideration figures specify neither currency nor per-unit basis. The 31 March period boundary also occurs in the later August notice; disclosed rows are distinct and retained separately.","sha256":"28b6b6a8ec93e66124cdc955203e1de12c4dda74bccb7540a50997b6f951bae8","source_id":"2924-02938608-6A1261068","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change in substantial holding","triage":{"classification":"relevant","reason":"Substantive holder notice and full transaction annexure reviewed; consideration currency and unit basis are not stated.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02938608-6A1261068"},"2924-02947537-6A1264894":{"category":"security_event","collected_at":"2026-10-09T18:26:43.481779Z","page_count":5,"published_at_utc":"2025-05-16T06:38:00Z","relative_path":"2025/2025-05-16_547d49bcda236a6d86193bbd.pdf","review_note":"Reviewed the complete Appendix 3H. It reports 197,778 service rights lapsed on 16 May 2025 because conditions were unmet. Cross-source reconciliation matches that reduction to Andrew Bantock's Define Super Fund balance: 296,667 granted in the 2023 3Y and 98,889 remaining in the 2025 annual report.","sha256":"7cda8c495e3c2263fa0d87a3ef1162ec817c5fc2d8fe1b971c6fd84f75fa3c6c","source_id":"2924-02947537-6A1264894","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02947537-6A1264894"},"2924-02979360-6A1278607":{"category":"director_interest","collected_at":"2026-10-09T18:26:42.969517Z","page_count":3,"published_at_utc":"2025-08-17T22:23:40.000Z","relative_path":"2025/2025-08-18_de46703d7951080d81ce547b.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"6e6fb93b2a3f7cb36c9df4ed47244a564aaee5053f18d3507157c13ccb1ca239","source_id":"2924-02979360-6A1278607","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice - Scott Perry","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02979360-6A1278607"},"2924-02980904-6A1279178":{"category":"holder_notice","collected_at":"2026-10-09T18:26:41.378415Z","page_count":5,"published_at_utc":"2025-08-20T02:22:09.000Z","relative_path":"2025/2025-08-20_33e4ced60c6166dba9067cad_verified.pdf","review_note":"Reviewed all five pages and all 67 Annexure A rows, including an 8,257-share buy omitted in the earlier 66-row transcription. Corrected source row locators while preserving existing event IDs. The resulting net change of -4,031,840 shares matches the reported change from 41,999,990 to 37,968,150. The annexure labels figures only as consideration without currency or per-unit basis; unsupported AUD prices and calculated cash remain withheld.","sha256":"31288aa8ec8bad6a2bca2129dc3351f2381aa61b64bee8d9a867081775778905","source_id":"2924-02980904-6A1279178","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change in substantial holding","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02980904-6A1279178"},"2924-02995811-6A1284825":{"category":"shareholder_list","collected_at":"2026-10-09T17:46:11.949886Z","page_count":78,"published_at_utc":"2025-09-19T06:44:13Z","relative_path":"2025/2025-09-19_Annual Report to shareholders.pdf","review_note":"Reviewed the annual report including director interests and top-20 context. Page 76 reports 98,889 Service Rights in Andrew Bantock's Define Super Fund account at 30 June 2025; this is used only to reconcile the May 2025 issuer-wide lapse, not as a transaction.","sha256":"09014e27a455d1187d5b81fd4c602c41dca7b6b1a57c4977e3ece6d63bb29496","source_id":"2924-02995811-6A1284825","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Annual Report to shareholders","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02995811-6A1284825"},"2924-03001245-6A1287305":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:39.750402Z","page_count":1,"published_at_utc":"2025-09-30T07:47:00.000Z","relative_path":"2025/2025-09-30_6a73caf8715a80306ddd554b.pdf","review_note":"Reviewed the one-page date notice. It only supplies the planned 2025 AGM date and refers to a later notice for resolutions; it contains no award or holder transaction terms.","sha256":"0756833c40afae1f95b92c848b0677512ed9f48e9cc24ca6b68ac884069b5d90","source_id":"2924-03001245-6A1287305","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of AGM Date","triage":{"classification":"background_only","reason":"Meeting scheduling information only; substantive matters are in the separately reviewed AGM notice.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03001245-6A1287305"},"2924-03004071-6A1288546":{"category":"holder_notice","collected_at":"2026-10-09T18:26:35.310073Z","page_count":3,"published_at_utc":"2025-10-06T05:49:14.000Z","relative_path":"2025/2025-10-06_5b9d8b67d835bd81a0b40bcf_verified.pdf","review_note":"All three pages read and all 159 rows of the readable-text Annexure 1 reviewed, with rendered page checked across its full length and securities/votes compared row by row. It reports 65 on-market purchases, 91 on-market sales and three off-market transfer entries; opposite-signed transfers remain separate as printed and are not assumed to be one economic trade. The form gives cessation date 30 September 2025 but its appendix also includes 1\u20132 October changes; these are retained as disclosed. It provides no post-cessation position. Dollar consideration does not explicitly identify currency.","sha256":"aee7e048bb2fd50da4a6eecb04f156ef6c27bb93722ad8306c5a3fa4136c2623","source_id":"2924-03004071-6A1288546","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Ceasing to be a substantial holder","triage":{"classification":"relevant","reason":"Substantive holder notice and full transaction annexure reviewed; consideration currency and post-cessation balance are not stated.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03004071-6A1288546"},"2924-03007940-6A1290173":{"category":"security_event","collected_at":"2026-10-09T18:26:34.310920Z","page_count":10,"published_at_utc":"2025-10-14T06:59:14.000Z","relative_path":"2025/2025-10-14_7663c509df2d5030cfdd844d.pdf","review_note":"Reviewed all 10 pages. KMP allotments name Shane McBride in associated trust/company accounts; issuer Board and Management page identifies him as CFO/Company Secretary, not a director. These awards do not establish a transaction by a director or major holder.","sha256":"9e3445652837f432a7dcd3f899e8cd33ad43939016f644cb94b73773c84209dc","source_id":"2924-03007940-6A1290173","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"The KMP transactions are attributable to the non-director CFO/Company Secretary Shane McBride and do not affect Directors or Major holders coverage.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03007940-6A1290173"},"2924-03009980-6A1291112":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:33.695181Z","page_count":49,"published_at_utc":"2025-10-17T06:38:44.000Z","relative_path":"2025/2025-10-17_996d11a9d23ed6638fe8f91a.pdf","review_note":"Reviewed the full AGM notice and relevant explanatory pages. Resolutions 3-5 seek approval for 695,837 Perry options, 432,570 Stephen Mann options and Murray Hill service-option/LTI/STI awards subsequently issued on 2 December; other resolutions cover remuneration, director election, NED fee pool and placement capacity. The director securities are already captured from the later 3Y filings.","sha256":"308b22975308cf0876cc14b7fc9e0a87d736ebad9a66e1af2df3622d7f7fb618","source_id":"2924-03009980-6A1291112","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of Annual General Meeting/Proxy Form","triage":{"classification":"relevant","reason":"It sets out proposed named director awards and placement-capacity context, both cross-checked against later executed notices.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03009980-6A1291112"},"2924-03009983-6A1291114":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:31.237969Z","page_count":1,"published_at_utc":"2025-10-17T06:42:09.000Z","relative_path":"2025/2025-10-17_582c2fec5ff1b969f5c5630f.pdf","review_note":"Reviewed the one-page access letter. It only tells holders how to obtain the AGM notice and adds no transaction terms.","sha256":"a19f812c23dacc176321eadf6b387e772d5fe3c7f11b5003f9ebffbd2d2e931d","source_id":"2924-03009983-6A1291114","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"NOM Materials Access Letter","triage":{"classification":"background_only","reason":"Administrative access letter; the substantive AGM resolutions are contained in the separately reviewed notice.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03009983-6A1291114"},"2924-03009987-6A1291117":{"category":"security_event","collected_at":"2026-10-09T18:26:29.403275Z","page_count":7,"published_at_utc":"2025-10-17T06:54:09.000Z","relative_path":"2025/2025-10-17_c7b7d3ffd6694b9bd6fe64ea.pdf","review_note":"Reviewed all seven Appendix 3B pages. It proposes the director option/right issues later approved and issued on 2 December; the actual named allocations and terms are captured in the subsequent Appendix 3Ys and Appendix 3G.","sha256":"9f4dcc4a409f163f94cdc03d4293a1c2b6ecd5b6600fba8843ddaa12c668c3e2","source_id":"2924-03009987-6A1291117","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"This is approval/proposal context for named director securities, not an executed award at the proposal date.","views":["directors"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03009987-6A1291117"},"2924-03017125-6A1294577":{"category":"investment_release","collected_at":"2026-10-09T18:26:28.233353Z","page_count":5,"published_at_utc":"2025-10-30T22:41:27.000Z","relative_path":"2025/2025-10-31_74d013c754aa3011d73708f7_verified.pdf","review_note":"Reviewed all five release pages. Pages 1-3 disclose the $25m placement of 71,428,572 ordinary shares at $0.35, settled 6 November and allotted 7 November 2025; they name the managers/co-manager but not participant allocations. The 2026 meeting notice supplies Paradice's exact allocation.","sha256":"6f4e6fa79cd1b6d683f700b9438de94e42d99cde987df1a08e845813c3482a3f","source_id":"2924-03017125-6A1294577","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"$25M to Accelerate U-pgrade Plant and Resource Drilling","triage":{"classification":"relevant","reason":"The release confirms placement economics and allotment timing; it does not itself identify each holder's participation.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03017125-6A1294577"},"2924-03017127-6A1294585":{"category":"security_event","collected_at":"2026-10-09T18:26:26.577700Z","page_count":5,"published_at_utc":"2025-10-30T22:41:37.000Z","relative_path":"2025/2025-10-31_888593a0898db4c8d168a967.pdf","review_note":"Reviewed the complete Appendix 3B for the 71,428,572-share placement. It sets out aggregate placement terms; individual investors are not named, and later Appendix 2A and the meeting notice establish issue and the Paradice allocation.","sha256":"f4dadf5ca3b3cb1874668efc2affbc616dd39ef87cec190ea66382bdda06dc08","source_id":"2924-03017127-6A1294585","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"Placement terms and aggregate issue context are relevant to holder-event reconciliation; no unnamed subscribers are imputed.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03017127-6A1294585"},"2924-03020308-6A1295991":{"category":"security_event","collected_at":"2026-10-09T18:26:26.076546Z","page_count":8,"published_at_utc":"2025-11-06T22:50:43.000Z","relative_path":"2025/2025-11-07_91d73eb78c7a87ef29394e06.pdf","review_note":"Reviewed all Appendix 2A pages. It confirms issue/quotation of 71,428,572 ordinary shares on 7 November 2025 at $0.35 and post-issue ordinary capital of 457,044,384; named subscriber allocations are supplied by the later meeting notice, not this aggregate form.","sha256":"e5c3607e3892da265ad661f98c98e29afb47361eb48f51174206cbf9931203c7","source_id":"2924-03020308-6A1295991","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed placement count, date, price and post-issue capital are necessary for holder transaction reconciliation.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03020308-6A1295991"},"2924-03022181-6A1296679":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:23.168331Z","page_count":4,"published_at_utc":"2025-11-12T05:39:27.000Z","relative_path":"2025/2025-11-12_2b22654778ceb91bde09cde9.pdf","review_note":"Reviewed the four-page addendum. Pages 3-4 update the disclosure for the already-issued 7 November placement: 38,560,000 shares were issued under 10% capacity, and no related party/KMP/substantial holder/advisor/associate received more than 1% of post-issue capital from that tranche. Paradice's disclosed 7,066,983-share allocation is above 1% of pre-issue capital and therefore is not assigned to this tranche; the source does not identify which 15% tranche subscribers received individual allocations.","sha256":"e6ae43801c5b83ce0926aeaa9dcdf95ffd79ff930673a11321230432b6504b84","source_id":"2924-03022181-6A1296679","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"ADDENDUM TO NOTICE OF GENERAL MEETING","triage":{"classification":"relevant","reason":"The addendum constrains interpretation of the placement allocation and prevents attributing Paradice to the 10% tranche absent evidence.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03022181-6A1296679"},"2924-03022182-6A1296680":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:21.870464Z","page_count":1,"published_at_utc":"2025-11-12T05:39:52.000Z","relative_path":"2025/2025-11-12_bcb79d5b004a1276ce4c3548.pdf","review_note":"Reviewed the one-page notification letter. It only reports an addendum to the meeting materials; the actual capital-capacity disclosure is reviewed separately.","sha256":"b01751c70a79bd8c4a4da7a54213b56500e882dbcb4e23f73658bcad66d8d064","source_id":"2924-03022182-6A1296680","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"ADDENDUM NOTIFICATION LETTER","triage":{"classification":"background_only","reason":"Administrative notification only, with no standalone transaction terms.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03022182-6A1296680"},"2924-03024252-6A1297478":{"category":"holder_notice","collected_at":"2026-10-09T18:26:20.823363Z","page_count":5,"published_at_utc":"2025-11-17T21:46:58Z","relative_path":"2025/2025-11-18_1b0706f2e896d13ba758dfa5.pdf","review_note":"Visually reviewed all five pages including scanned Annexure A. Transcribed 69 rows (26 purchases totaling 3,477,712 shares; 43 sales totaling 4,337,636); net decrease 859,924 reconciles prior 37,968,150 to present 37,108,226 voting shares (8.119%) at 6 November 2025. Printed consideration figures are retained in original wording only because currency and unit-price basis are not established.","sha256":"5cbbcded4a192bb4e8f6418ecfeb1201977552b5ef4c1f1ac65296b143072b3b","source_id":"2924-03024252-6A1297478","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change in substantial holding","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03024252-6A1297478"},"2924-03029442-6A1299670":{"category":"meeting_result","collected_at":"2026-10-09T18:26:18.603684Z","page_count":2,"published_at_utc":"2025-11-27T03:48:41.000Z","relative_path":"2025/2025-11-27_f2e542666ad67e0f6aa857a3.pdf","review_note":"Reviewed the full two-page 2025 AGM result. Resolutions 3\u20135 approving Scott Perry service options, Stephen Mann service options, and Murray Hill service options/LTI/STI rights passed by poll; later 3Y notices report actual issue.","sha256":"329e1f87b4fdf1348ec87ca9c63ada2b11279a2e76dd9497d23fb753b5714b8b","source_id":"2924-03029442-6A1299670","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Results of Meeting","triage":{"classification":"relevant","reason":"Confirms shareholder approval context for actual director grants subsequently reported in the 2 December 2025 Appendix 3Y notices.","views":["directors"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03029442-6A1299670"},"2924-03029881-6A1299846":{"category":"security_event","collected_at":"2026-10-09T18:26:17.166890Z","page_count":7,"published_at_utc":"2025-11-27T21:55:27.000Z","relative_path":"2025/2025-11-28_2200a9bf594f34b6f077d08e.pdf","review_note":"Reviewed the complete amended Appendix 3B. It updates shareholder approval and 2 December issue timing for director options/rights; the actual aggregate 3G and named director 3Ys are filed on 2 December and are already represented in the candidate.","sha256":"75c987e56aeca3333d9f51344db7b3bf1ec923f7bb307ed8869b317b2423dbc6","source_id":"2924-03029881-6A1299846","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The update links approval to the subsequent named director grants; it is proposal/timing context rather than an additional grant.","views":["directors"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03029881-6A1299846"},"2924-03032143-6A1301053":{"category":"director_interest","collected_at":"2026-10-09T18:26:16.641376Z","page_count":10,"published_at_utc":"2025-12-02T06:21:58.000Z","relative_path":"2025/2025-12-02_1f127d5e92b83760cca293e0.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"7c827df0b9d21b654c42e5fdfd21484ec62af43c648ff563ec37b14a927eaa57","source_id":"2924-03032143-6A1301053","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice x 3","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03032143-6A1301053"},"2924-03032144-6A1301049":{"category":"security_event","collected_at":"2026-10-09T18:26:12.499865Z","page_count":10,"published_at_utc":"2025-12-02T06:22:13.000Z","relative_path":"2025/2025-12-02_197834130d95b5dd273f5804.pdf","review_note":"Reviewed all ten Appendix 3G pages. Pages 5-6 report the 2 December issue of 2,865,711 service options, 658,245 LTI rights and 647,454 STI rights; the named director allocations and terms are already captured in the corresponding same-day Appendix 3Ys and reconcile to these totals.","sha256":"75288580d7bb40a9fe7fa0f200d6fa8f036b41dd6ef1e7a2420284293c57f6e6","source_id":"2924-03032144-6A1301049","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"relevant","reason":"The issue is an aggregate confirmation of the named director award rows and does not add unallocated holder activity.","views":["directors"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03032144-6A1301049"},"2924-03038527-6A1303920":{"category":"security_event","collected_at":"2026-10-09T18:26:12.017835Z","page_count":5,"published_at_utc":"2025-12-17T01:39:42.000Z","relative_path":"2025/2025-12-17_ec3c979a6a3e336ba2f69887.pdf","review_note":"Reviewed the full Appendix 3H. It reports expiry of 4,200,000 EL8AG options on 16 December 2025 at $0.61 exercise price. Existing director Appendix 3Ys attribute 2,500,000 of this class to Carmu Super Fund and Tracy Mann; the remaining 1,700,000 is not allocated to a named director or holder.","sha256":"8deaa34acde7fc47d92a31889032b8867cd433b921dd1a54622ac21efdc661d0","source_id":"2924-03038527-6A1303920","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","triage":{"classification":"relevant","reason":"The class expiry reconciles against named director notices but the remainder cannot be attributed beyond issuer-wide scope.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03038527-6A1303920"},"2924-03038701-6A1303990":{"category":"director_interest","collected_at":"2026-10-09T18:26:11.482705Z","page_count":7,"published_at_utc":"2025-12-17T06:31:53.000Z","relative_path":"2025/2025-12-17_a8e6858d3e8b1ad05f345709_verified.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"732a2886b8c6f858737461d7c33f5df02e44d62959ee51a8ac265a8563e5f07f","source_id":"2924-03038701-6A1303990","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice X 2","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03038701-6A1303990"},"2924-03040917-6A1304945":{"category":"security_event","collected_at":"2026-10-09T18:26:09.521504Z","page_count":5,"published_at_utc":"2025-12-22T22:53:57.000Z","relative_path":"2025/2025-12-23_56d7b471b39f2aef3efd3106.pdf","review_note":"Reviewed the complete Appendix 3B. It proposes the 8,923,738 Core Lithium consideration-share issue subsequently quoted in the 23 December Appendix 2A, with no cash and no named director or substantial-holder allocation.","sha256":"372d51b2413d4a077ef765eb4b39849abbc56b07e176ffc5a7368d56d2fd036d","source_id":"2924-03040917-6A1304945","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The proposal and later completed Appendix 2A explain the issuer capital issue; the named recipient is not a substantial holder.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03040917-6A1304945"},"2924-03040964-6A1304990":{"category":"security_event","collected_at":"2026-10-09T18:26:09.018882Z","page_count":8,"published_at_utc":"2025-12-22T23:48:38.000Z","relative_path":"2025/2025-12-23_02431431589dbc04b0aefd6b.pdf","review_note":"Reviewed all eight Appendix 2A pages. Pages 1 and 5-6 report 8,923,738 ordinary shares issued on 22 December 2025 at deemed $0.2802 per share as 50% non-cash acquisition consideration to Core Lithium; page 6 identifies Core as neither related party nor substantial holder. No named in-scope holder event is disclosed.","sha256":"5f831222c159c1bbfb291dcb9e538052c69f99ed2289c83468653b074bd7f5a7","source_id":"2924-03040964-6A1304990","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed issuer share issue and post-issue capital are relevant to holder-position context, while Core Lithium is expressly not a substantial holder.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03040964-6A1304990"},"2924-03044892-6A1306562":{"category":"holder_notice","collected_at":"2026-10-09T18:26:08.534210Z","page_count":3,"published_at_utc":"2026-01-09T05:20:31.000Z","relative_path":"2026/2026-01-09_d5663c812840202ce1cb95bc.pdf","review_note":"All three scanned pages visually reviewed. Annexure B has 23 transaction rows; consideration values have no stated currency or price basis, so no cash or unit price is inferred.","sha256":"6a06aebdfbec1c1eea9f27a47bd13967f500b1a54bbb8c4fab953434026d472b","source_id":"2924-03044892-6A1306562","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Ceasing to be a substantial holder","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03044892-6A1306562"},"2924-03048341-6A1308123":{"category":"director_interest","collected_at":"2026-10-09T17:46:11.930529Z","page_count":4,"published_at_utc":"2026-01-22T06:39:08.000Z","relative_path":"2026/2026-01-22_Change of Director's Interest Notice_601ac7952002016b.pdf","review_note":"Reviewed all pages and annexures for issuer identity, transaction scope, class, date, and relevant account or security changes.","sha256":"9db2d4363566ad69c06148ebcc7ee6364eec9455fa1324b94f805d529b9f9321","source_id":"2924-03048341-6A1308123","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03048341-6A1308123"},"2924-03052577-6A1310344":{"category":"security_event","collected_at":"2026-10-09T18:26:06.582061Z","page_count":5,"published_at_utc":"2026-02-03T06:39:46Z","relative_path":"2026/2026-02-03_c58fc2ed37abecf613f5b956.pdf","review_note":"Reviewed the full Appendix 3H. On 30 January 2026 the issuer reported expiry of 14,904,798 options, equal to the full 11,904,798 Placement Option class plus the 3,000,000 Broker Option class. The 2023 prospectus allocation supports Cumulus Wealth's separate 1,500,000-option portion of that expiry.","sha256":"a0afd39e5049b99d38cc51f97e95383d9ee75649d4b2120c6fadc222bd4bf5b2","source_id":"2924-03052577-6A1310344","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03052577-6A1310344"},"2924-03077213-6A1319884":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:06.075507Z","page_count":22,"published_at_utc":"2026-04-09T06:33:14.000Z","relative_path":"2026/2026-04-09_74dc00d0b104bbbda33aab8d.pdf","review_note":"Reviewed the full notice and explanatory statement. Resolutions 1 and 2 ratify the already-issued 7 November 2025 placement and Core Lithium consideration shares; the proposed employee incentive scheme and any grants under it are not executed events. Page 8 identifies Paradice Investment Management Pty Ltd and David Paradice by association as substantial holders allocated 7,066,983 placement shares; page 6 gives the 7 November issue date and $0.35 price. The allocation's gross cash amount is calculated as 7,066,983 x $0.35, not disclosed as a separate allotment total. The cited 1.83% is the filing's issue-time capital ratio, not a reported post-issue holder balance.","sha256":"5e09439ed546ff47b20d55179eb90d9eab484ec88f85b0ea172983fb327b3df7","source_id":"2924-03077213-6A1319884","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of General Meeting/Proxy Form","triage":{"classification":"relevant","reason":"The notice identifies an executed share allocation to an existing substantial holder and distinguishes it from the aggregate placement and proposed employee scheme.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03077213-6A1319884"},"2924-03077219-6A1319885":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:04.785172Z","page_count":1,"published_at_utc":"2026-04-09T06:38:44.000Z","relative_path":"2026/2026-04-09_27063c542cfb6ca92f312a67.pdf","review_note":"Reviewed the one-page NOM access letter. It only provides delivery/access information for the separate general-meeting notice and contains no transaction or holder-position evidence.","sha256":"c6e8713d51ab89c16e5f5294fffa5da76a3268cb467bf84a628dc0fb9704dbd7","source_id":"2924-03077219-6A1319885","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"NOM Materials Access Letter","triage":{"classification":"background_only","reason":"Administrative access letter only; substantive resolutions and placement disclosures are in the separately reviewed 9 April 2026 notice.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03077219-6A1319885"},"2924-03087410-6A1324414":{"category":"security_event","collected_at":"2026-10-09T17:46:11.929632Z","page_count":6,"published_at_utc":"2026-05-06T07:59:44Z","relative_path":"2026/2026-05-06_Notification of cessation of securities - EL8.pdf","review_note":"Reviewed all pages and annexures; issuer-wide capital or background information disclosed no individual director or substantial-holder transaction relevant to these views.","sha256":"4d0b7eb01ed8a511310969cdfb1e7b49deb75e63340364aaffeea59475d28bb3","source_id":"2924-03087410-6A1324414","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","triage":{"classification":"background_only","reason":"Issuer-wide securities/capital or annual-report material inspected; it disclosed no transaction by a named director or substantial holder and does not change reviewed account or holder evidence.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03087410-6A1324414"},"2924-03088313-6A1324744":{"category":"meeting_result","collected_at":"2026-10-09T18:26:03.414371Z","page_count":2,"published_at_utc":"2026-05-08T04:16:46Z","relative_path":"2026/2026-05-08_1809b7becbe75672dc01fbee.pdf","review_note":"Reviewed the 8 May 2026 results. Relevant resolutions passed for placement shares, Core Lithium acquisition shares, and employee-scheme securities; these supply approval/capital context only.","sha256":"a51b9a3ff7eb0c66307daa1ed0a64cbda2cb0771fc118c6928d243bf18d357ac","source_id":"2924-03088313-6A1324744","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Results of Meeting","triage":{"classification":"relevant","reason":"The results explain authority for subsequent securities issuance and employee awards; the resolutions themselves are not individual transactions or positions.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03088313-6A1324744"},"2924-03110333-6A1333570":{"category":"security_event","collected_at":"2026-10-09T18:26:01.945295Z","page_count":5,"published_at_utc":"2026-07-12T23:41:31Z","relative_path":"2026/2026-07-13_Proposed issue of securities - EL8.pdf","review_note":"Reviewed the 13 July Appendix 3B proposing shares as partial consideration for the Marenica/Xanthos acquisition. The later July issue updates describe proposed shares; no in-scope holder transaction is identified in this proposal.","sha256":"ea76ae2d9a25ddabb95c78d0f6609106dbdf3b63a754b3588fd3de16c9128798","source_id":"2924-03110333-6A1333570","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"It provides context for proposed acquisition-share dilution without evidencing a completed holder transaction.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03110333-6A1333570"},"2924-03114959-6A1335785":{"category":"security_event","collected_at":"2026-10-09T17:46:11.929302Z","page_count":8,"published_at_utc":"2026-07-28T06:42:11Z","relative_path":"2026/2026-07-28_Application for quotation of securities - EL8.pdf","review_note":"Reviewed all pages and annexures; issuer-wide capital or background information disclosed no individual director or substantial-holder transaction relevant to these views.","sha256":"f3320b887e782a60e3dc4d2d9be19c62bafea5c7aced17d902d06bb50b9c3657","source_id":"2924-03114959-6A1335785","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"background_only","reason":"Issuer-wide securities/capital or annual-report material inspected; it disclosed no transaction by a named director or substantial holder and does not change reviewed account or holder evidence.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03114959-6A1335785"},"2924-03114970-6A1335792":{"category":"security_event","collected_at":"2026-10-09T18:26:01.944767Z","page_count":5,"published_at_utc":"2026-07-28T06:59:16Z","relative_path":"2026/2026-07-28_Update - Proposed issue of securities - EL8.pdf","review_note":"Reviewed the update to the proposed Marenica/Xanthos acquisition-consideration issue. It reports no additional executed issue or named director/substantial-holder event.","sha256":"3d9929b7ec133505a21a8cc3c20cb7014f436dbe8f3dcc9d46bb3df236c4de56","source_id":"2924-03114970-6A1335792","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The proposed acquisition issue informs issuer-capital context but does not identify an in-scope holder transaction.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03114970-6A1335792"},"2924-03119190-6A1337794":{"category":"security_event","collected_at":"2026-10-09T18:26:01.943787Z","page_count":5,"published_at_utc":"2026-08-07T07:55:02Z","relative_path":"2026/2026-08-07_Update - Proposed issue of securities - EL8.pdf","review_note":"Reviewed the update to the proposed Marenica/Xanthos acquisition-consideration issue. It reports no completed issue or named director/substantial-holder transaction; completion is evidenced by the later October Appendix 2A.","sha256":"2737b04077f116cef466115fd0c1db7ea89522ac786edccb87b2312c30542091","source_id":"2924-03119190-6A1337794","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"The proposal is useful share-count context for holder percentages but does not identify a substantial-holder event.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03119190-6A1337794"},"2924-03130847-6A1341884":{"category":"security_event","collected_at":"2026-10-09T17:46:11.928737Z","page_count":5,"published_at_utc":"2026-09-02T06:13:21Z","relative_path":"2026/2026-09-02_Notification of cessation of securities - EL8.pdf","review_note":"Reviewed all pages and annexures; issuer-wide capital or background information disclosed no individual director or substantial-holder transaction relevant to these views.","sha256":"378a58612ef0040353e24738655ab1f991e53bebe6abb143ec91fbcac6ef0da8","source_id":"2924-03130847-6A1341884","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","triage":{"classification":"background_only","reason":"Issuer-wide securities/capital or annual-report material inspected; it disclosed no transaction by a named director or substantial holder and does not change reviewed account or holder evidence.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03130847-6A1341884"},"2924-03134671-6A1343448":{"category":"security_event","collected_at":"2026-10-09T17:46:11.928333Z","page_count":8,"published_at_utc":"2026-09-11T06:30:59Z","relative_path":"2026/2026-09-11_Application for quotation of securities - EL8.pdf","review_note":"Reviewed the complete Appendix 2A. The KMP security conversion identifies Shane McBride; issuer Board and Management page identifies him as CFO/Company Secretary, not a director. Out of scope for Directors and Major holders.","sha256":"91ecb1e12a1a079997e8ba1aac1151182a23ebde840853a30e6c908cda696476","source_id":"2924-03134671-6A1343448","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"background_only","reason":"The identified KMP conversion is by the non-director CFO/Company Secretary Shane McBride; it does not affect Directors or Major holders coverage.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03134671-6A1343448"},"2924-03134673-6A1343449":{"category":"security_event","collected_at":"2026-10-09T17:46:11.927669Z","page_count":5,"published_at_utc":"2026-09-11T06:32:04Z","relative_path":"2026/2026-09-11_Notification of cessation of securities - EL8.pdf","review_note":"Reviewed all pages and annexures; issuer-wide capital or background information disclosed no individual director or substantial-holder transaction relevant to these views.","sha256":"0eb023b6cf824472f084996b731d7bb66d7eff38c145b1179a94a9e34b2849c0","source_id":"2924-03134673-6A1343449","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of cessation of securities - EL8","triage":{"classification":"background_only","reason":"Issuer-wide securities/capital or annual-report material inspected; it disclosed no transaction by a named director or substantial holder and does not change reviewed account or holder evidence.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03134673-6A1343449"},"2924-03134678-6A1343454":{"category":"director_interest","collected_at":"2026-10-09T18:26:01.939122Z","page_count":4,"published_at_utc":"2026-09-11T06:41:39.000Z","relative_path":"2026/2026-09-11_7a508a32ae2e13c8ea064044_verified.pdf","review_note":"Issuer, full notice pages and annexures reviewed; supported records below include all disclosed relevant transactions or the notice is a position-only/role notice.","sha256":"fc71adf6d38854e62beded14ff5cd19cfbd6561d6e5441c3f456358a86c29891","source_id":"2924-03134678-6A1343454","state":"reviewed","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Change of Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03134678-6A1343454"},"2924-03142617-6A1346899":{"category":"security_event","collected_at":"2026-10-09T18:26:00.354536Z","page_count":5,"published_at_utc":"2026-09-30T08:12:10Z","relative_path":"2026/2026-09-30_Update - Proposed issue of securities - EL8.pdf","review_note":"Reviewed the update to the proposed Marenica/Xanthos acquisition-consideration issue. It changes proposal timing only, reports no additional completed issue, and identifies no director or substantial-holder transaction.","sha256":"26343f813ccd431be8d17b571be4dccad6b302ae063b3301056be78ce70fac6e","source_id":"2924-03142617-6A1346899","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Update - Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"It explains proposed capital/dilution timing, but is not an executed issue or holder notice.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03142617-6A1346899"},"2924-03145020-6A1347920":{"category":"meeting_notice","collected_at":"2026-10-09T18:26:00.353429Z","page_count":1,"published_at_utc":"2026-10-06T05:41:16Z","relative_path":"2026/2026-10-06_d968454e9d41bd81f3c53a4b.pdf","review_note":"Reviewed the one-page AGM date notification. It supplies only the meeting date; proposal details are in the later notice.","sha256":"02c108dce0f8e110831a1d32409158013ff912d87dd8f19b2550c06b6944fd03","source_id":"2924-03145020-6A1347920","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification of Annual General Meeting Date","triage":{"classification":"background_only","reason":"Administrative meeting-date notice only, with no in-scope transaction terms.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03145020-6A1347920"},"2924-03148921-6A1349441":{"category":"shareholder_list","collected_at":"2026-10-31T19:37:52.346474Z","page_count":88,"published_at_utc":"2026-10-15T06:30:04Z","relative_path":"2026/2026-10-15_Annual Report to shareholders_015e10759b66fe24.pdf","review_note":"Reviewed director/KMP role and interest disclosures, 30 June 2026 top-20 table, and options/rights pages. The top-20 list is a dated registered-holder snapshot; its last-notified substantial-holder percentages are not treated as current trades or balances.","sha256":"972ef290b78a840192327ccd136b715df4ea6ce3b5414bfd3ecca3c98f538e62","source_id":"2924-03148921-6A1349441","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Annual Report to shareholders","triage":{"classification":"relevant","reason":"Dated director-interest, registered-holder and capital context helps classify accounts and percentages, but the report does not report the underlying interval trades.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03148921-6A1349441"},"2924-03152544-6A1351059":{"category":"meeting_notice","collected_at":"2026-10-31T19:37:52.336167Z","page_count":54,"published_at_utc":"2026-10-23T06:33:22Z","relative_path":"2026/2026-10-23_Notice of Annual General Meeting_Proxy Form_ccdeed0af611f0fe.pdf","review_note":"Reviewed the 25 November 2026 AGM notice and proxy form. It includes proposed director options/rights, a Xanthos share-issue ratification and a proposed director election. These remain proposals after the evidence cutoff; no event is recorded.","sha256":"98eecca0072e4860f019479c61fa4307588ca2c50ffdd607a89160c70fead0f8","source_id":"2924-03152544-6A1351059","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notice of Annual General Meeting/Proxy Form","triage":{"classification":"relevant","reason":"The notice supplies context for proposed director incentives and capital approvals, but none were approved or issued by 2 November 2026.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03152544-6A1351059"},"2924-03152546-6A1351061":{"category":"meeting_notice","collected_at":"2026-10-31T19:37:52.334638Z","page_count":1,"published_at_utc":"2026-10-23T06:35:32Z","relative_path":"2026/2026-10-23_NOM Material Access Letter_0f5e70d056c24f17.pdf","review_note":"Reviewed the one-page access letter. It only directs shareholders to AGM materials and adds no transaction or holder-position evidence.","sha256":"1cd178f5b8adbd908c5345d834a34add0a3c8d35e1be5dc1a3b62c15f5fba091","source_id":"2924-03152546-6A1351061","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"NOM Material Access Letter","triage":{"classification":"background_only","reason":"Administrative notice with no transaction-relevant content beyond availability of the separately reviewed AGM materials.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03152546-6A1351061"},"2924-03152614-6A1351087":{"category":"security_event","collected_at":"2026-10-30T16:45:58.469428Z","page_count":7,"published_at_utc":"2026-10-23T08:54:42Z","relative_path":"2026/2026-10-23_Proposed issue of securities - EL8_2924-03152614-6A1351087.pdf","review_note":"Reviewed the 23 October Appendix 3B with the AGM notice. It proposes service options/performance rights for Murray Hill and options for Stephen Mann and Stephen Perry, subject to the 25 November 2026 vote. No grant had occurred by cutoff.","sha256":"a40ba16b1b7de7e3feba63704cd26a861805b8288a636f5904321f1ae65dc8bd","source_id":"2924-03152614-6A1351087","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Proposed issue of securities - EL8","triage":{"classification":"relevant","reason":"This is approval context for proposed director awards and possible capital dilution, not an executed event or current holder position.","views":["directors","major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03152614-6A1351087"},"2924-03153205-6A1351400":{"category":"security_event","collected_at":"2026-10-31T19:37:52.333247Z","page_count":10,"published_at_utc":"2026-10-26T06:10:17Z","relative_path":"2026/2026-10-26_Notification regarding unquoted securities - EL8_78779b86bdf8f6d1.pdf","review_note":"Reviewed the complete Appendix 3G and grant terms. The named recipient is Shane McBride, CFO/Company Secretary and not a director; no substantial holder is identified.","sha256":"4dd176522b2c4f9f2b5281086c451f6b9cba9c8fd1ed668b86d1a08b3a357d0a","source_id":"2924-03153205-6A1351400","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Notification regarding unquoted securities - EL8","triage":{"classification":"background_only","reason":"The named recipient is a non-director executive, and the grant does not concern a substantial holder or a director transaction.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03153205-6A1351400"},"2924-03156502-6A1352997":{"category":"security_event","collected_at":"2026-10-31T19:37:52.332242Z","page_count":8,"published_at_utc":"2026-10-30T06:33:46Z","relative_path":"2026/2026-10-30_Application for quotation of securities - EL8_2924-03156502-6A1352997.pdf","review_note":"Reviewed the complete 30 October 2026 Appendix 2A. It reports 5,683,067 ordinary shares issued as non-cash consideration for the remaining 5% of Marenica Minerals. No director or substantial-holder recipient is identified; this is dated issuer-capital context, not a holder event.","sha256":"1df71f7391ecf9ebec5ba44fd86152b17af096e0e06bf209b609cf06356ed310","source_id":"2924-03156502-6A1352997","state":"supporting","subject_name":"Elevate Uranium Limited","subject_ticker":"EL8","title":"Application for quotation of securities - EL8","triage":{"classification":"relevant","reason":"The completed share issue changes share-count context for holder percentages, but the form does not identify an in-scope holder transaction.","views":["major_holders"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03156502-6A1352997"}},"status":"ready","summary":{},"ticker":"EL8","unresolved_count":0,"view":"directors","view_coverage":{"directors":{"basis":"declared","collection_issues":[],"coverage_start":"2023-01-01","explained_count":2,"material_issue_count":0,"minor_discrepancy_count":0,"newer_pending_count":0,"note":"All indexed substantive director notices and relevant meeting, grant, exercise, lapse, placement and annual-report context through 30 October 2026 were reviewed against the existing director rows. Director grants, exercises and lapses remain tied to named Appendix 3Y records; aggregate issuer issues are not assigned to a director without support.","notice_count":13,"pending_notice_count":0,"required_context_count":0,"reviewed_at":"2026-11-02T13:55:35Z","reviewed_notice_count":13,"reviewed_through":"2026-10-30","status":"complete","unclassified_note_count":0},"major_holders":{"basis":"declared","collection_issues":[],"coverage_start":"2023-01-01","explained_count":6,"material_issue_count":0,"minor_discrepancy_count":0,"newer_pending_count":0,"note":"All indexed substantial-holder notices and relevant placement, capital, meeting and annual-report sources through 30 October 2026 were reviewed. Paradice placement allocations are reconciled to its Form 604 and the 2024 and 2025 issuer filings; Cumulus allocations remain separate from issuer-wide option classes; unnamed placement subscriptions remain unallocated.","notice_count":12,"pending_notice_count":0,"required_context_count":0,"reviewed_at":"2026-11-02T13:55:35Z","reviewed_notice_count":12,"reviewed_through":"2026-10-30","status":"complete","unclassified_note_count":0}}}